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Abstract 
The Cra protein is a global regulator of carbon and energy metabolism for glycolysis and 
gluconeogenesis. The live oral vaccine candidate, Salmonella typhimurium SR-11 Fa£f, is llllable to 
utilize gluconeogenic substrates as sole carbon sources and is avirulent and protective in BALB/c 
mice. Furthennore, the era gene is interrupted in this strain of Salmonella. The era gene was 
suspected to be regulated by another global regulator, acetyl phosphate. To further investigate the 
regulation ofthe era gene and to determine if gluconeogenesis is linked to virulence, mutations in the 
gluconeogenic genesjbp (fructose-1,6-bisphosphatase), maeB (NADP-dependent malic enzyme), and 
sfeA (NAD-dependent malic enzyme) were constructed in S. typhimurium SR-11. A mutation in the 
pta (phosphotransacetylase) gene was also constructed to interrupt acetyl phosphate synthesis. 
Virulence assays in BALB/c mice were performed with these mutant strains. A era promoter-lacZ 
transcriptional fusion was also inserted into the chromosome of these mutant strains to assay for the 
era promoter activity during growth on various glycolytic and gluconeogenic substrates. 
The SR-1 lfbp-, SR-11 maeE, SR-11 sfeA- mutant strains were virulent in BALB/c mice, 
whereas the pta- mutant strain was avirulent. The mutation in the maeB gene slightly down-regulated 
the era promoter activity when grown on either gluconeogenic or glycolytic substrates versus the SR-
11 cradl craz integrant control strain. A mutation in either the sfeA gene or the pta gene significantly 
(P = 0.05) up-regulated the era promoter activity for growth·on both gluconeogenic and glycolytic 
substrates versus the control strain. This up-regulation of era promoter activity, combined with their 
virulence in BALB/c mice, suggest that the sfrA-encoded NAD-dependent malic enzyme and acetyl 
phosphate act in concert as a repressor of the era gene. It also appears that the era gene may be subject 
to regulation by multiple regulatory proteins or multiple forms of regulation. 
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Introduction 
General introduction. Salmonella species cause a variety of foodbome and waterborne 
illnesses ranging from localized gastroenteritis to systemic diseases such as typhoid fever in both 
humans and animals (1-3). The life-threatening diseases such as enteric fever, septicemia, and the 
focal infections, osteomyelitis and meningitis, caused by Salmonella involve invasion of the bacteria 
into the blood, the reticuloendothelial system and other organs (3). 
How does Salmonella wreak such havoc in humans and animals? This facultative 
intracellular parasite, containing a 50-90 kbp virulence plasmid, has evolved an arsenal of toxins and 
mechanisms of pathogenesis to invade and destroy euk:aryotic cells, while evading the immune system 
of the host cell (4-6). Fundamentally, the outer membrane of this motile gram-negative bacterium 
contains lipopolysaccharide (LPS) (7, 8). This endotoxin, specifically the lipid A component, is 
pathogenic in humans and other mammals (8, 9). 
Most Salmonella infections result from the ingestion of contaminated water or food (2). The 
ingested microorganisms proceed to the intestinal tract (2). The bacteria then adhere to specialized 
small intestinal epithelial cells, called microfold cells (M cells), via long polar fimbriae ( 10). These 
facultative intracellular parasites produce a breach in the intestinal wall via the M cell and ultimately 
reach the lamina propria of the Peyer's patches (2, 10, 11). At this site, the bacteria may replicate and 
establish a local infection, or they may be ingested by macrophages which may disseminate these 
microorganisms to deeper tissues such as regional lymph nodes, the liver, and the spleen to establish a 
systemic infection (2). Salmonella possesses the ability to not only survive in and kill macrophages, 
but also to replicate within them and other constituents of the reticuloendothelial system (2-5, 10). 
An estimated 1.4 million cases of salmonellosis, resulting in approximately 500 deaths, occur 
annually in the United States (12, 13). Half of the sahnonellosis cases are caused by two serovars: 
Salmonella enterica serovar Typhimurium and serovar Enteritidis (12, 14). The health care costs 
associated with human salmonellosis caused by eating contaminated eggs and poultry is estimated at 
$4 billion annually (15). Typhoid fever, a disease caused by the bacterium Salmonella enterica 
serovar Typhi, still remains a serious public health problem in developing countries with 16 million 
cases of typhoid fever causing an estimated 600, 000 deaths annually ( 16, 17). Scilmonella typhi 
appears to be a human-specific pathogen, mtlike S. typhimurium, which colonizes many animals as 
well as humans (18). 
Poultry production also is significantly reduced by Salmonella bacteria (15). The U.S. poultry 
industry hatches approximately 7.5 billion eggs annually in incubation facilities, and nearly $77 
million is lost each year due to Sa1monella outbreaks in poultry farms (15). Vaccination of chickens 
against Salmonella would reduce losses to the poultry industry and poultry-associated human 
salmonellosis. 
Animal models. Although S. typhimurium can cause disease in numerous non-human 
animals, many animal carriers of S. typhimurium do not show any signs of disease (19). The rhesus 
monkey is the animal that most resembles htmlans in its response to a S. typhimurium infection ( 19). 
The guinea pig model also appears to closely mimic the disease in humans (19). Yet, these animal 
models are not used by most investigators ( 19). Most investigators use mice are routinely used as the 
animal model for reasons of cost and convenience ( 19). More importantly, the disease caused by S. 
typhimurium in mice is not the gastroenteritis observed utilizing the other animal models ( 19). The 
disease caused by S. typhimurium in mice mimics typhoid fever in humans and is well accepted as a 
model for human typhoid (20). Whatever the reason for the difference between mice and primates, 
htllllans and other primates usually control the infection within a week, whereas in mice the bacteria 
spread to the liver and spleen before the animal can mount an effective protective response (21 ). 
Acid tolerance response. After ingestion of Salmonella, the acid tolerance response allows 
the microorganisms to survive passage through the acidic environment of the stomach, a prerequisite 
for infection (22, 23). S. typhimurium can survive well in vitro at pH values down to about pH 4, but 
below that rapid death of the bacteria is observed (23). However, cells given a chance to adapt (growth 
for one generation at pH 6), can survive at pH values as low as pH 3 for prolonged periods. The acid 
tolerance response appears to be regulated by the Fur protein (22, 23). Fur is required for the acid-
induced activation of atr genes and the expression of iron uptake systems under iron-limiting 
conditions (22). Fur appears to be sensing and responding to pH as well as iron (23). 
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More recently, another acid tolerance response has been identified (23). This response is 
controlled by the PhoP-Ph~ two-component regulatory system, which regulates the expression of 
many of the virulence genes in S. typhimurium (23). The acid tolerance response seems to be co-
regulated with the modulation of genes in helping the bacteria survive and invade once they reach the 
intestine. This is the first time such a clear connection between the acid tolerance response and the 
general virulence response has been found (23). 
Two-component regulatory systems. Two-component regulatory systems (phosphorylation-
dependent signal transduction systems) act like switches (24 ). One component, referred to as the 
sensor (such as the periplasmic sensor Ph~, is a histidine kinase protein (24, 25). This protein binds 
ATP and is autophosphorylated at a conserved histidine residue. The second component of the switch 
formed by two-component regulatory systems is known as the response regulator (such as PhoP) (24, 
25). The response regulator protein contains a domain that is transiently phosphorylated on a 
conserved aspartyl residue (24 ). Phosphoryl groups are transferred from the histidine residue of the 
sensor to the conserved aspartyl residue of the response regulator, which activates the response 
regulator protein (25). The activated response regulator protein is involved in the regulation of 
transcription of genes (25). 
The expression of many of the virulence genes in S. typhimurium is regulated by PhoP-Ph~ 
in response to changes in pH and the concentration of divalent cations such as Mg2+ and Ca2+ (25). 
Limiting concentrations of extracellular divalent cations activate the system, resulting in the net 
phosphorylation of PhoP by Ph~. Phosphorylated PhoP interacts with the promoters of PhoP-Ph~ 
regulated genes and activates or represses transcription of these genes (24, 25). 
Examples of PhoP-Ph~ gene regulation include the activation of mgtA, a gene encoding a 
high affinity Mg2+ transporter and activation of the hi/A and sir A genes, which are also involved the 
regulation of Salmonella virulence genes (25, 26). PhoP-Ph~ is thought to repress Salmonella 
pathogenicity island 1 (SPI-1; large segments of DNA found in S. typhimurium but not in the 
nonvirulent E. coli strain K 12) invasion genes while activating expression of pags (PhoP activated 
genes) (22, 26). These pags include the mgtCB operon, which also encodes a high affinity Mg2+ 
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uptake system, and genes on SPI2 (22). PhoP-PhoQ has also been implicated in modulating another 
putative two-component signal transduction system: PmrA-PrmB. PmrA binds to and activates 
promoters of certain pags, including several whose products alter LPS in vitro. Members of the PmrA 
regulon, includingpmrCAB itself: are activated by PhoP-PhoQ (22). 
Adherence and invasion. After passage and survival through the mouse stomach, S. 
typhimurium reaches the ileum, a section of small intestine attached to the cecum (21-23). Short-chain 
fatty acids in the distal ileum provide the signal for productive infection by Salmonella (27). The 
rising concentration of acetate and the low concentration of oxygen in the distal ileum provide the 
signal for invasion gene expression (27, 28). 
S. typhimurium has a preference for the Peyer's patches in mice (21). Peyer's patches belong 
to a group of organized lymphoid tissues known collectively as the mucosal-associated lymphoid 
tissue which defend vulnerable membrane surfaces (11). The mucosal-associated lymphoid tissue 
carries an extremely large population of antibody-producing plasma cells. Lymphoid cells are found in 
three regions of the vulnerable mucus membrane which lines the gastrointestinal tract. The outer 
mucosal layer contains intraepithelial lymphocytes: T-cells which express unusual T-cell receptors and 
exhibit limited diversity for antigens (11). Below the outer mucosal layer is the lamina propria, which 
contains large numbers of B cells, plasma cells, activated helper-T cells, and macrophages in loose 
clusters. Below the lamina propria, still within the submucosal layer, are nodules consisting of30-40 
organized lymphoid follicles, called tlie Peyer's patches (11 ). 
The epithelial cells of mucous membranes play an important role in promoting the imrrume 
response by delivering small samples of foreign antigen from the digestive tract to the tmderlying 
mucosal-associated lymphoid tissue (11). This antigen transport is carried out by specialized M cells, 
which contain a deep invagination in the basolateral membrane filled with a cluster ofB cells, T cells, 
and macrophages (10, 11 ). Antigens transported across the mucous membrane by M cells activate B 
cells. B cells differentiate into plasma cells which secrete the IgA class of antibodies. These 
antibodies are then transported across the epithelial cells and released as secretory IgA into the hunen 
where they can interact with antigens present in the lumen (11 ). It is the M cell that is the major site of 
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invasion for S. typhimurium in mice (11, 21, 29). Other intestinal cells, called enterocytes, are the 
minor site of invasion for Salmonella in the murine model (28, 29). 
S. typhimurium produces a number of adhesins for entry via the M cell (30). These include 
type 1 funbriae (encoded by fim genes), plasmid-encoded fimbriae (pefgenes), long polar fimbriae (/pf 
genes), and thin aggregative fimbriae (curli; encoded by agf genes). The binding specificity of type 1 
fimbriae is tmknown (30). The pef genes are located on the 90 kbp plasmid, called the virulence 
plasmid (pSL n, which is found in all virulent strains of S. typhimurium. These plasmid-encoded 
funbriae mediate binding of the bacteria to the microvilli of enterocytes (30). The long polar fimbriae 
mediate attachment to the Peyer's patches. The thin aggregative fimbriae called curli may aid in 
attachment to the microvilli of enterocytes, but they also cause the bacteria to become attached to each 
other (30). The gene rck encodes a surface protein which acts as an adhesin and may be involved in 
invasion of tissue culture cells. The surface protein also increases the resistance of S. typhimurium to 
killing by complement (30). 
Shortly after coming into close contact with the host cell, Salmonella induces profound 
changes in the brush border of the intestinal epithelium, characterized by the denaturation ofmicrovilli 
at the point of contact between the bacteria and the host cell membrane (31 ). Interactions of S. 
typhimurium with M cells also leads to membrane ruffi.ing (31 ). Salmonella forces the host cells to 
engulfit (32). Membrane ru:ffiing and internalization of the bacteria within a membrane-bound vesicle 
are accompanied by extensive actin-rriediated cytoskeletal and cell surface rearrangements in the 
vicinity of the invading bacteria (10, 32). 
Once internalized, S. typhimurium destroys the M-cell and enters macrophages in the 
mesenteric lymph follicles (10, 33, 34). Macrophage survival is now important for Salmonella because 
it enables the evasion of the imrmme system (2, 10, 22). Salmonella-infected macrophages may 
disseminate to deeper tissues such as regional lymph nodes, liver, and spleen to establish a systemic 
infection (2, 10, 22). Salmonella possesses the ability to not only survive in and kill macrophages, but 
also to replicate within them and other constituents of the reticuloendothelial system (2-5, 10, 22). For 
example, S. typhimurium can enter and survive within hlllllan B and T cells, which could play a role in 
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the dissemination of infection (31 ). Furthermore, Salmonella can gain access to non-phagocytic cells 
of the liver and spleen, which may constitute a "safe site" for replication during the early phases of 
systemic infection (31 ). Overall, the main sites of replication during systemic infections in mice are 
the liver and spleen (35). Jn vivo studies have shown that S. typhimurium resides in CDl 8-positive 
leukocytes in the liver and replicates in red pulp and scavenger receptor-expressing marginal zone 
macrophages in the spleen (35). 
Upon reaching the liver and spleen, the bacteria must continue to survive and replicate in 
order to cause disease in mice (22). Several genes whose products alter LPS structure and promote 
polymyxin resistance in vitro may aide S. typhimurium resist killing by PMN- and macrophage-
produced cationic peptides at systemic sites. Also, genes on the Salmonella virulence plasmid are 
required for bacterial replication in these tissues (22). As the bacteria proliferate, they produce lipid A, 
promoting inflammatory cytokine and inducible nitric oxide responses (iNOS) that may kill the murine 
host (9, 22). 
Virulence gene clusters. Many clusters of virulence genes are found in S. typhimurium 
including three Salmonella pathogenicity islands (SPI-1, 2, 3), two lysogenic phages (Gifsy-1, 2), and 
a 90 kb virulence plasmid (pSL D (22, 36). In addition to the genes which code for a type III secretion 
system and its secreted proteins, SPI-1 contains genes which code for chaperones that control folding 
of proteins, and regulatory proteins (PhoP-PhoQ, HilA, InvF., SirA). SPI-2 carries genes for a second 
type III secretion system along with the genes encoding the proteins secreted by the second type III 
secretion system (22). Genes encoding chaperones that control protein folding are also found on SPI-2 
(36). SPI-2 is involved in inhibition ofphagosome-lysosome fusion and is important during the 
systemic phase of disease (36). SPI-3 carries genes encoding a high affinity Mg2+ transporter and 
proteins oftmknown function (26, 36). SPI-3 may aid in the survival and growth of Salmonella in the 
Mg2+-poor vacuole of the invaded cell (36). 
So far only a few genes carried on the lysogenic phages Gifsy-1 and Gifsy-2 have been 
characterized (26, 36). Gifsy-2 carries a sod.CJ gene encoding superoxide dismutase (26, 37, 38). This 
enzyme, which converts toxic superoxide to less toxic peroxide, may help the bacteria survive the 
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macrophage oxidative burst (26, 36). Gifsy-2 also carries a gene (gtgE) that encodes the protein gtgE, 
which is necessary for full virulence in S. typhimurium (38). Gifsy-1 and Gifsy-2 may contribute to 
survival during the systemic phase of infection (36). 
The virulence plasmid (pSL n carries a gene for fimbrial adhesion (pef), an adhesion/sennn 
resistance gene (rck), and genes coding for Spv proteins. The SpvB protein is a toxin that ADP-
ribosylates actin (36, 39). Other spv genes encoded within pSLT are required for bacterial replication 
in the reticuloendothelial system (39). S. typhimurium carries the conjugal transfer gene traTmaking it 
self-transmissible (39). The virulence plasmid is important in all phases of infection (36). 
Type m secretion system required for initial invasion. A type III secretion system is an 
essential basic virulence determinant utilizing a conserved mechanism of protein secretion (34). 
However, the secreted proteins themselves are highly divergent. Salmonella is the only genus known 
to possess two type III secretion systems (34). These two type III systems appear to play different 
roles during pathogenesis: the first being required for initial penetration of the intestinal mucosa and 
the second necessary for subsequent systemic stages of infection (22, 34). 
The inv genes, along with other genes on SPI-1 (spa, prg, and org), encode the first type III 
secretion system (26, 28). The inv genes on SPI-1 are responsible for the membrane rufiling 
associated with invasion of cells by S. typhimurium (26). SPI-1 also carries the genes that encode the 
proteins that are injected into the eukaryotic cell by the type in secretion system (26). These genes 
include sptP, which encodes a tyrosine phosphatase that mimics signal transduction enzymes of 
eukaryotic cells and may play a role in altering the response of mucosal cells to outside stimuli (26). 
SopE and SipA are additional proteins injected into the mucosal cells via the type III secretion system 
(26, 34). These proteins are thought to be responsible for the ruflling response (26). SopE can activate 
host cell G proteins such as Cdc42 and Rae, which control actin polymerization. Activation of these 
proteins by SopE initiates the actin rearrangements involved in the ruffling response. Ruffling is a 
very localized phenomenon; localization of the host cell's response is thought to be the role ofSipA 
(26). SipA binds actin directly and inhibits depolymerization, thus increasing the amount of 
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polymerized actin in its vicinity. SipA is confined to the immediate area in which the bacteria are 
found, accounting for the localized nature of the ruflling phenomenon (26). 
Survival of Salmonella in macrophages. Macrophages are phagocytic cells capable of 
ingesting and digesting exogenous antigens such as whole bacteria ( 40). S. typhimurium enters host 
macrophages and can induce either an almost immediate cell death or establish an intracellular niche 
within the phagocytic vacuole ( 41 ). Rapid cell death depends on the SipB effector on Salmonella 
pathogenicity island SPI-1 and the host protein caspase-1 (35,41). Caspase-1 is a member of the pro-
apoptotic caspase family of proteases, and the process was originally thought to be apoptotic (3 5, 41 ). 
Recent studies suggests that it is an tmusual form of necrosis (35). Caspase-1-dependent cell death 
leads to the activation of the potent pro-inflammatory cytokines interleukin (IL)-lp and IL-18 to 
produce bioactive cytokines (41). Animal studies indicate that the activation of these cytokines is 
necessary for infection and efficient colonization of the mmine gastrointestinal tract ( 41 ). Salmonella 
that reside in the phagocytic vacuole do not cause this early cell death and are capable of triggering 
macrophage death at a much later time point ( 41 ). This late-phase cell death is dependent upon genes 
encoded on the Salmonella pathogenicity island SPI-2 and the transcription factor OmpR ( 41, 42). 
After uptake, Salmonella resides within a unique organelle, the Salmonella-containing 
vacuole (SCV; Salmonella-containing phagosome) in which it eventually replicates (43). Studies of 
the S. typhimurium vacuole in macrophages have been hampered by its heterogeneous behavior (35). 
Infection of primary macrophages or a macrophage cell line by a culture of s. typhimurium results in 
variable numbers of bacteria in each host cell (35). For example, twelve hours after bacterial uptake, 
some macrophages contain clusters of numerous bacteria, while in others only a few dispersed bacteria 
are visible (35). This probably reflects the simultaneous processes of growth and killing that occur in 
murine macrophages (35). 
There are also conflicting results regarding the fusion of the SCV with lysosomal 
compartments (35). Two groups concluded from studies involving primary macrophages that SCV s 
fuse with lysosomal compartments (35). Conflicting evidence suggests that Salmonella can inhibit 
phagosome-lysosome (SCV-lysosome) fusion in both primary macrophages and macrophage-like cell 
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lines (35, 44). Despite this, a consensus has emerged over the last few years that is generally 
consistent with the current llllderstanding ofSCVs (35). According to this, the majority ofSCVs 
acidify but fail to acquire lysosomal hydrolytic enzymes or reactive oxygen intermediates that would 
normally accumulate in a phagolysosome (35). There is evidence that both the PhoP-PhoQ two-
component regulatory system and SPI-2 type III secretion system play important roles in this process, 
which leads to the establishment of a compartment which is conducive to bacterial replication (35). 
Replicating bacteria remain in membrane-bound vacuoles, and this requires a continuous supply of 
membrane to enclose dividing bacterial cells. The SPI-2 effector protein SifA, and the assembly of an 
actin mesh work, play major roles in this aspect of intracellular growth (35). 
Genes required for the survival and replication of Salmonella in macrophages. The 
interior of a macrophage can be a very inhospitable environment for a bacterium. However, S. 
typhimurium has acquired an arsenal of genes involved in the survival and replication inside 
macrophages (35). Many of the genes' fimctions are still unknown. Genes encoded within SPI-2 
involved with the SPI-2 type ill secretion system and their function are as follows: ssaC (subunit 
forming the outer membrane secretin porin), ssaV(secretion ofSPI-2 proteins), sseA (required for 
survival and replication), sseBCD (translocation of SPI-2 effectors), sseFG (interaction of phagosomal 
membranes after translocation; contributes to Sif formation in epithelial cells), sse.J (regulates the 
dynamics of the SCV membrane), ssrAB (two-component s~tem regulating SPI-2 gene expression), 
spiC (inhibition of trafficking; actin polymerization), and NC (the gene has not been characterized but 
is associated with SPI-2 secretion and involves inhibition of the oxidative burst) (35, 45-48). 
Survival and replication of Salmonella in macrophages requires other genes associated with 
the SPI-2 type Ill secretion system, which are encoded outside ofSPI-2 (35). The genes and their 
function are as follows: ompR-erwZ (two-component system regulating the acid-induced ssrAB 
virulence operon expression), sifA (contributes to Sif formation in epithelial cells and maintains the 
SCV membrane), srjK (unknown but regulated by ssrAB), and sse.J (required for translocation of 
effector proteins) (35, 48-50). 
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Many genes, required for the survival and replication of Salmonella in macrophages, are 
controlled by the PhoP-PhoQ regulon (35). These include mgtC (magnesium acquisition), NC (the 
gene has not been characterized but it is involved in the inhibition of SCV-late endosomal interactions) 
andpags (PhoP activated genes; LPS modification and resistance to antimicrobial peptides) (35). 
Other genes, neither associated with the SPI-2 type III secretion system nor controlled by the 
PhoP-PhoQ regulon, are required for the survival and replication of Salmonella in macrophages (9, 22, 
35, 36, 42, 45-55). The genes and their fimction are as follows: spvB (ADP-ribosylation of actin), 
sod.A and ssp.J (resistance to oxidative stress), slyA (regulates resistance to oxidative stress), pre 
(periplasmic protease), hrtA (stress-induced serine protease), rpoE (stress response regulator), smpB 
(unknown fimction),feoB (ABC ferrous iron transporter), mntH (proton-dependent manganese 
transporter), and sitABCD (putative ABC iron and/or manganese transporter), Ion (ATP-dependent 
protease), zw/(glucose-6-phosphate dehydrogenase, the product of the first enzymatic step in the 
pentose pathway; resistance to reactive oxygen and nitrogen intermediates via NADPH), sodCJ 
(superoxide dismutase; intercepts reactive oxygen species), sodCJJ (intercepts reactive oxygen 
species), htrA and surA (intramacrophage survival; protein folding and/or degradation in the 
periplasm),.fkpA (peptidylprolyl isomerase; invasion and survival) waaN (biosynthesis oflipid A; 
induces cytokine and inducible nitric oxide synthase (iNOS) responses) virK and somA (remodeling of 
the outer bacterial membrane), and msgA (unknown fimction) (9, 22, 35, 36, 42, 51-55). 
Regulation of virulence gen.es by two-component signal transduction systems. Several 
two-component signal transduction systems regulate virulence genes in vitro (22). PhoP-PhoQ and 
PmrA-PrmB are two which have already been discussed in detail (see Acid tolerance response, Two-
component regulatory systems, and Genes required for the survival and replication of Salmonella in 
macrophages). Evidence indicates that PhoR-PhoB, which regulates genes in response to inorganic 
phosphate {PJ concentration, can repress SPI-1 invasion genes (22). PhoR-PhoB may also activate 
SPI-2 genes because their expression is induced by low Pi levels in vitro. OmpR-EnvZ, a two-
component regulatory system that modulates gene expression in response to osmotic conditions and 
pH, may also regulate virulence genes because disrupting this regulatory pathway decreases SPI-1 
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gene expression (22, 50). Furthermore, recent evidence indicates that OmpR may play a role in 
regulation ofSPI-2 genes (10, 22). Two other two-component signal transduction systems, SsrA-SsrB 
and BarA-SirA, respond to l.ll1known environmental cues (22). SsrA-SsrB regulates SPI-2 gene 
expression of the SPI-2 type ill secretion system as well as its translocated effectors; SsrA-SsrB is in 
tum regulated by the OmpR-EnvZ two-component system (22, 50, 56). BarA-SirA is necessary for 
full expression of invasion genes on SPI-1 and SPI-4 (22~ 27). Another two-component system, CsrA-
CsrB, alters RNA stability which may modulate invasion gene expression (22). Finally, the superoxide 
radical response regulon, SoxR-SoxS, can upregulate the expression of the Tef gene, which confers 
resistance to reactive oxygen and nitrogen intermediates via NADPH (53). 
Regulation of virulence genes by alternative sigma factors. The alternative sigma factor, 
RpoS, which controls many genes expressed in stationary phase and for stress protection, also 
regulates virulence genes (57, 58). RpoS is necessary for sustaining a log-phase acid tolerance 
response, induction of a stationary-phase acid survival system, production of thin aggregative fimbriae, 
and expression of spv genes during stationary phase (22). The rpoE gene, which encodes the 
extracytoplasmic stress response sigma factor sigmaE (RpoE), is critically important for the virulence 
of S. typhimurium ( 59). RpoE regulates many genes required for survival in macrophages and proteins 
involved in protein folding and/or degradation in the periplasm (53, 54, 59). 
Other mechanisms of regulation for virulence genes. The DNA adenine methylase enzyme 
(dam), which modifies GATC sequences, has pleiotropic effects on the expression of many different 
virulence genes (22, 60, 61). To begin with, Dam methylation regulates the expression ofplasmid-
encoded fimbriae (pef) encoded by the pSL T virulence plasmid (22, 36, 61 ). The conjugative transfer 
of this virulence plasmid, which requires thefinP-encoded F-type pili, is regulated by the levels of 
Dam methylation; the transfer of the pSLT virulence plasmid is elevated by low levels of Dam 
methylation (61). A dam- mutation in S. typhimurium revealed reduced secretions of invasion effectors 
encoded in SPI-1 genes (22, 62). In addition, a reduction in the relative amount of peptidoglycan-
associated lipoprotein, OmpA (a highly immunogenic, non-specific, outer membrane porin, and 
murein lipoprotein bound to peptidoglycan was observed in actively growing Dam- mutants, indicating 
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increased cell envelope instability (62). The Danf mutant was wiable to proliferate in target organs in 
vivo but persisted in low numbers (63). Use of the Heal loop assay revealed that Dam· mutants were 
less cytotoxic to M-cells and failed to invade enterocytes (63). In the tissue culture model, lack of 
DNA adenine methylation reduced the ability of the bacteria to invade non-phagocytic cells (63). 
Collectively, these results indicate that DNA methylation plays several roles in regulating virulence 
genes in S. typhimurium (22, 62, 63). 
Other regulators specifically modulate the expression of virulence genes whose products are 
thought to have related fimctions (22). For example, the regulators RtsA, HilA, InvF, HilC, HilD, and 
HilE directly or indirectly modulate the expression of genes encoding the SPI-2 type III secretion 
system and its secreted effectors (22, 64-66). FimZ and AgfD are two other regulators believed to 
modulate specific virulence genes of related fimction and are required for in vitro expression of type I 
:fimbriae and thin aggregative fimbriae (22). . 
Many regulators control the expression of multiple virulence genes (22, 67). The global 
regulator CRP ( catabolite repressor protein) regulates a variety of genes in Salmonella in response to 
the levels of cAMP (67). CRP negatively regulates the spv operon on the Salmonella virulence 
plasmid, while positively regulating various fimbrial operons (67). ThefliZ gene positively regulates 
the expression of class II flagellar genes and induces SPI-1 invasion gene expression (22). 
Growth requirements and central fueling pathways of S. typhimurium. E.coli, studied 
more extensively than S. typhimurium, requires the synthesis of twelve precursor metabolites for 
growth: glucose-6-phosphate, fructose-6-phosphate, ribose-5-phosphate, erythrose-4-phosphate, triose-
3-phosphate (glyceraldehyde-3-phosphate ), 3-phosphoglycerate (from glycerate-1,3-bisphosphate ), 
phospho{enol)pyruvate, pyruvate, acetyl coenzyme A (acetyl-CoA), a-ketoglutarate, succinyl-CoA, 
and oxaloacetate ( 68, 69). Since S. typhimurium contains homologues for the enzymes in the~pathways 
that synthesize these precursor metabolites, it is assumed that S. typhimurium grows essentially the 
same (except ~ere noted) as E.coli (70, 71). 
These twelve precursor metabolites, except acetyl-CoA, are synthesized by a series of central 
fueling pathways that are collectively called central metabolism (72, 73). Central metabolism includes 
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the Embden-Meyerhof-Pamas (EMP) pathway, which converts glucose-6-phosphate to pyruvate; the 
tricarboxylic acid (TCA) cycle, which oxidizes acetyl-CoA to C02; and the pentose phosphate cycle, 
which oxidizes glucose-6-phosphate to C02 (Figure 1) (72-74). Acetyl-CoA is synthesized by a linker 
reaction between the EMP pathway and the TCA cycle (72). The Entner-Doudoroffpathway is also 
utilized by S. typhimurium to metabolize gluconate (Figure 1) (72, 73). Regardless of the fueling 
reactions that S. typhimurium employs, these twelve precursor metabolites are synthesized and are the 
metabolic link between fueling and biosynthesis ( 68). 
The precursor metabolites, along with inorganic ions, are required for the biosynthesis of 
cellular components (75, 76). For example, glucose-6-phosphate yields the sugar backbone of 
nucleotides, and fructose-6-phosphate is converted to amino sugars (69). Ribose-5-phosphate is the 
precursor metabolite for purine and pyrimidine nucleotides as well as the heptose component of LPS 
(67, 74). Erythrose-4-phosphate is utilized for the biosynthesis of aromatic amino acids (69, 76). 
Triose-3-phosphate (glyceraldehyde-3-phosphate) is the precursor metabolite for the biosynthesis of 
nicotinamide coenzymes and phospholipids (76). The biosynthesis of the amino acids serine, glycine, 
cysteine, and tryptophan use 3-phosphoglycerate as their precursor metabolite (69, 76). 
Phospho( enol)pyruvate is the building block for vitamins and cofactors as well as aromatic amino 
acids. Pyruvate is utilized for the biosynthesis of the amino acids alanine, valine, leucine, and 
isoleucine (69, 76). Acetyl-CoA is the precursor metabolite ~or fatty acids and the outer membrane 
component murein. The amino acids glutamate, glutamine, arginine, and proline are all synthesized 
from a-ketoglutarate (67, 74). The precursor metabolite succinyl-CoA is used to form heme (76). 
Finally, the oxaloacetate is the precursor metabolite for the biosynthesis of the amino acids aspartate, 
asparagine, threonine, methionine, and isoleucine (68, 69). 
There is tremendous flexibility in the way the central fueling pathways operate (72). For 
example, formation of the precursor metabolites during aerobic growth of S. typhimurium on a limiting 
source of glucose utilizes a major anapleurotic reaction (74, 77-79). Anapleurotic reactions are the 
interconnecting, reversing, and bypassing reactions which replenish the pools of precursor metabolites 
drained by biosynthesis (68). This anapleurotic reaction, catalyzed by the pJX-encoded enzyme 
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phospho( enol)pyruvate carboxylase, forms oxaloacetate by carboxylation of phospho( enol)pyruvate 
(Figure 1) (77). Components of the TCA cycle function almost exclusively to provide three precursor 
metabolites, not as an energy-generating cycle (77). 
Aerobic growth of S. typhimurium on a gluconeogenic substrate such as malate is extensively 
different from growth on a glycolytic substrate such as glucose: TCA components are shunted off into 
the EMP pathway to form the required precursor metabolites (77). Two routes lead from malate to 
pyruvate in the EMP pathway; the maeB- and efcA-encoded malic oxidoreductase enzymes catalyze 
these redundant reactions (Figure 1) (71, 77, 80, 81). Oxaloacetate is converted to 
phospho(enol)pyruvate and also shunted off into the EMP pathway (Figure 1) (77). A reversal of flow 
in the EMP pathway, called gluconeogenesis, occurs (72, 73, 77, 82). Gluconeogenesis leads to the 
pentose phosphate cycle and both produce the remaining precursor metabolites (72, 77). Tue total cost 
of fueling reactions operating to produce precursor metabolites is much greater for a gluconeogenic 
substrate, such as malate, than for a glycolytic substrate such as glucose (83). Therefore, growth on 
gluconeogenic substrates, such as malate, is slower than growth on glycolytic substrates such as 
glucose (77). 
Levels of nutrients and oxygen at specific locations in the S. typhimurium infection 
process. The level of nutrients are high and the oxygen level is very low in the lumen and mucus of 
the ileum (28, 33, 84). Inside the M cell, or epithelial cell vaeuole, the nutrient and oxygen levels are 
both low (84). Inside macrophages, the level of nutrients is low and the oxygen level is moderate (35, 
84 ). The spleen contains high levels of nutrients and oxygen (28, 85). S. typhimurium replicates in the 
CD18-positive leukocytes in the liver which are bathed by hepatic blood vessels (35, 85). It is 
assumed that both the levels of nutrients and oxygen are moderate to high. The levels of oxygen 
appear to be from microaerophillic to aerobic at all the specific locations of the S. typhimurium 
infection process (28, 33, 35, 85). 
G lycolysis and the utilization of glycolytic substrates. Glycolysis, also called the Embden-
Meyerhof-Parnas (EMP) pathway, is the metabolic pathway utilized to break down glucose to pyruvate 
(73, 87-89). Four important events occur during glycolysis; { 1} substrate-level phosphorylation which 
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is the synthesis of adenosine triphosphate (ATP) by the donation of a high-energy phosphate to 
adenosine diphosphate (ADP) from a reaction coupled with the exergonic breakdown of a high-energy 
substrate molecule, {2} the breaking of the six-carbon glucose molecule into two three-carbon 
pyruvate molecules, and {3} the transfer of two electrons to the coenzyme nicotinamide adenine 
dinucleotide (NAD~ to form NADH + H + (87, 89). 
The usual route for glucose uptake and phosphorylation is the phospho( enol)pyruvate 
phosphotransferase system (P'fS) (73). The PTS transports and simultaneously phosphorylates glucose 
in a process called group translocation (90). The PTS in S. typhimurium contains general PTS proteins 
and proteins specific for glucose transport (91 ). The general PTS proteins, enzyme I (EI) and histidine 
protein (Hpr) are the soluble cytoplasmic proteins that participate in the phosphorylation of all PTS 
carbohydrates (91). EI and Hpr in S. typhimurium are encoded by the genes ptsH and ptsl respectively 
(90-92). The EIIGlc enzyme is glucose-specific, membrane-bound, encoded by the gene ptsG, and 
consists of two domains: IIC-IIB (90, 91, 93). The final component, the err-encoded enzyme IIA Glc, is 
soluble (91, 92, 94). All of the PTS enzymes and proteins participate, in sequence, in the transfer of a 
phosphoryl group to glucose (91 ). Glucose phosphorylation is coupled to glucose translocation across 
the cytoplasmic membrane, the energy for these processes being provided by the glycolytic 
intermediate phospho( enol)pyruvate (91 ). 
Another enzyme, the g/k-encoded glucokinase, plays a minor role in glucose metabolism (73, 
95, 96). Under anabolic stress the enz)'me may be required to supplement the levels of glucose-6-
phosphate (95). Both the PTS and glucokinase yield the first glycolytic intermediate: glucose-6-
phosphate (Figure 1) (73, 91, 95). 
The interconversion of glucose-6-phosphate to fructose-6-phosphate by the enzyme 
glucosephosphate isomerase (pgi) is the next step in glycolysis (Figure 1) (73, 97, 98). Fructose-6-
phosphate is then phosphorylated to form fructose-1,6-bisphosphate by a pair of isozymes, 6-
phosphofructokinase-I (pjkA) and 6-phosphofructokinase-II (pjkB) (73, 88, 99-102). These reactions 
are irreversible and provide one of the key control points for glycolysis (82). The main 
phosphofructokinase is PFK-1 since it is 9-fold more active than PFK-II (73, 97, 99). PFK-1 is 
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activated allosterically by nucleoside diphosphates (ADP and GDP) and inhibited by 
phospho(enol)pyruvate (73, 100). PFK-1 is somewhat sensitive to inhibition by fructose-1,6-
bisphosphate and ATP (100). 
S. typhimurium contains genes for both the fructose bisphosphate aldolase Class II enzyme 
(jba) and the fructose bisphosphate aldolase Class I enzyme (jbaB) (73, 92, 93, 103, 104). These 
enzymes split fructose-1,6-bisphosphate into dihydroxy-acetone-phosphate and glyceraldehyde-3-
phosphate (Figure 1) (73, 103, 104). The fructose bisphosphate aldolase Class II enzyme requires 
divalent metal ions such as Zn2+, Co2+, Fe2+, Ni2+, or Mn2+ (73, 103). 
In the subsequent reactions of glycolysis, triose phosphate isomerase (tpiA) interconverts 
dihydroxy-acetone-phosphate and glyceraldehyde-3-phosphate (Figure 1) (73, 92, 105). Next, the 
glyceraldehyde-3-phosphate dehydrogenase-A complex (gapA) converts glyceraldehyde-3-phosphate 
to glycerate-1,3-bisphosphate (73, 92, 106, 107). The reaction adds a phosphate group while NAD+ is 
reduced to NADH (87, 106, 107). A subsequent sequence of reactions occurs for the conversion of 
glycerate-1 ,3-bisphosphate to phospho( enol)pyruvate (73). The sequence of reactions include the 
enzymes phosphoglycerate kinase (pgk), phosphoglycerate mutase 1 (gpmA), phosphoglycerate mutase 
2 (gpmB), phosphoglyceromutase (pmgl), and enolase (eno) (73, 92, 93, 108-114). ATP is produced in 
this sequence of reactions by substrate-level phosphorylation (89). 
The last step in glycolysis is the conversion of phospho( enol)pyruvate to pyruvate by the 
isozymes, pyruvate kinase I (pykF) and pyruvate kinase II (pyk:A) (73, 115-118). ATP is produced in 
these reactions by substrate-level phosphorylation (89). These reactions are irreversible and provide a 
second key control point for glycolysis (Figure 1) (82). Both pyruvate kinases require divalent and 
monovalent cations, usually Mg2+ and K+ ( 117). Pyruvate kinase I is activated by low Ca2+ and Mg2+ 
concentrations and is strongly activated by fructose-1,6-bisphosphate (73, 115). Inhibitors of pyruvate 
kinase I include succinyl-CoA, ATP, and high concentrations ofCa2+ (115). Pyruvate kinase II is 
activated by AMP and several sugar phosphates (73, 117). 
Phospho( enol)pyruvate can also bypass the conversion to pyruvate and take an alternate route: 
the enzyme phospho(enol)pyruvate carboxylase (ppc) converts it to oxaloacetate (Figure 1) (73, 92, 
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l 19). Phospho( enol)pyruvate carboxylase is a regulatory enzyme which replenishes oxaloacetate in 
the TCA cycle; oxaloacetate is the precursor of other intermediates of the TCA cycle and of major 
families ofbiosynthetic products (73, 119). Phospho(enol)pyruvate carboxylase is allosterically 
activated by acetyl-CoA, fructose-1,6-bisphosphate, guanosine triphosphate (G1P), and fatty acids 
(119). L-aspartate and malate allosterically inhibit phospho(enol)pyruvate carboxylase (119). 
For the purposes of this study, a glycolytic substrate is considered any carbohydrate such as 
glucose, fructose, and gluconate which enters the glycolytic (EMP) pathway. 
Gluconeogenesis and the utilization of gluconeogenic substrates. The EMP pathway is an 
amphibolic system and functions in both glycolysis and gluconeogenesis (82). Most of the reactions 
are reversible, with the notable exception of the 6-phosphofructokinase (pjkAB) and the pyruvate 
kinase (pykAF) catalyzed reactions which are glycolytic (Figure 1) (73, 82). These two steps in the 
Embden-Meyerhof pathway are replaced in the gluconeogenic pathway by thejbp-encoded enzyme 
fructoste-1,6-bisphosphatase and the pps-encoded enzyme phospho(enol)pyruvate synthetase (Figure 
1) (73, 82, 92, 120-123). Fructoste-1,6-bisphosphatase is inhibited by adenosine monophosphate 
(AMP), ADP, glucose-6-phosphate, and phospho(enol)pyruvate (92, 122). 
Three other reactions, involving TCA intermediates, are considered part of gluconeogenesis 
(73, 120). The enzyme phospho(enol)pyruvate carboxykinase (pckA) irreversibly converts 
oxaloacetate to phospho( enol)pyruvate, requires A 1P, and is inhibited by NADH, 
phospho(enol)pyruvate, and high concentrations of A1P (Figure 1) (73, 93, 120, 124). Two highly-
regulated malate oxidoreductases, an NADP-dependent malic enzyme (maeB) and an NAD-dependent 
malic enzyme (sfcA), irreversibly convert malate to pyruvate (73, 120, 123, 125, 126). The NADP-
dependent malic enzyme is activated by NH/ and K+ (125). This enzyme is both competitively 
inhibited by malonate and glutarate and also allosterically inhibited by oxaloacetate, acetyl-CoA, 
NAD+, NADP+, and cAMP (125). The NAD-dependent malic enzyme is allosterically activated by L-
aspartate and allosterically inhibited by A 1P, coenzyme A, and acetyl-CoA (126). Malate also 
activates this enzyme by an unknown mechanism (126). 
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For the purposes of this study, a gluconeogenic substrate is considered any substrate which 
enters the gluconeogenic pathway such as acetate, alanine, glycerol, citrate, fumarate, malate, oleate, 
phospho( enol)pyruvate, pyruvate, and succinate. 
The fate of pyruvate in S. typhimurium metabolism. The oxidation of hexoses, such as 
glucose, to pyruvate by the EMP pathway generates two molecules of pyruvate and two molecules of 
NADH (127). To maintain glycolytic flux, the NADH must be oxidized to NAD+ (127). One option 
for regenerating these reducing equivalents in the absence of oxygen is by a process called 
fermentation (127, 128). Fermentation occurs by depositing the reducing equivalents on partially 
oxidized metabolic intermediates, which are then excreted from the cell (127). The fermentation 
products comprise a mixture of ethanol, and acetic, formic, lactic, and succinic acids (127). Since the 
carbon atoms in the metabolic intermediates are only partially oxidized and the difference in reduction 
potentials between the primary electron donor and terminal electron acceptor is small, the fermentation 
processes yield little energy (129). 
Another option for regenerating these reducing equivalents which occurs in the presence of 
oxygen is a process called aerobic respiration; this process involves an electron transport system and 
oxidative phosphorylation (129-134). In this process which utilizes 0 2 as the final electron acceptor, 
all the substrate molecules can be oxidized completely to C02, and a far higher yield of ATP is 
theoretically possible ( 129-131 ). Two hydrogen atoms, each consisting of one proton and one 
electron, are transferred from NADH to a series of other carrier compounds (NADH dehydrogenases, 
flavoproteins, nonheme iron-sulfur proteins, quinones, and cytochromes) embedded within the cell 
membrane ( 130-134 ). This electron transport chain separates the protons from the electrons during the 
transport process (131, 133, 134). The protons are extruded into the periplasm; the net result is the 
generation of a pH gradient and an electrical potential across the membrane, with the inside of the 
cytoplasm electrically negative and alkaline, and the outside of the membrane electrically positive and 
acidic (131, 133, 134). Membrane-bound catalytic A TPases act as proton channels which drive the 
formation of ATP from ADP plus inorganic phosphate (131, 133, 134). This ATP-producing process 
is known as oxidative phosphorylation (131, 133, 134). 
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Aerobic respiration via the TCA cycle and oxidative phosphorylation require that pyruvate 
first be converted to acetyl-CoA (131, 133, 134). Acetyl-CoA is synthesized by a linker reaction 
between the EMP pathway and the TCA cycle (72). The pyruvate dehydrogenase multienzyme 
complex ( aceEF, lpdA), one of the most complicated enzyme systems known, converts pyruvate to 
acetyl-CoA (92, 135). NAD+ is reduced to NADH and COi is generated in the reaction (135). 
Inhibitors of the reaction include glyoxylate, 2-oxobutanoate, pyruvate, and high concentrations of 
NAD+ (135). 
The TCA cycle and glyoxylate bypass. The TCA cycle is an inducible pathway with the 
levels of the enzymes responding primarily to the presence of oxygen and to the carbon source(s) 
available (7 4 ). The levels of the TCA cycle enzymes are also regulated at the transcriptional level by 
the interaction of two global regulatory systems: catabolite (glucose) repression and the ArcA-ArcB 
two-component regulatory system ( 136). The full TCA cycle is fi.mctional only during aerobic growth 
on acetate or fatty acids (Figure 1) (74). However, growth on acetate or fatty acids requires the 
induction and fimction of an anapleurotic pathway, the glyoxylate shunt, to replenish the dicarboxylic 
acid intermediates consmned in amino acid biosynthesis. (74, 137, 138). 
Citrate synthase (gltA), the rate-limiting step in the TCA cycle, converts oxaloacetate plus 
acetyl-CoA to citrate (Figure 1) (74, 92, 139). The synthesis of the enzyme is subject to catabolite 
repression and induced by 0 2 when acetate is the carbon source (74, 139). The enzyme is activated by 
acetyl-CoA and K+ ions and inhibited by 2-oxoglutarate, ATP, NADH, oxaloacetate, and NAD+ (7 4, 
139). 
There are two aconitases in S. typhimurium, aconitate hydrotase 1 ( acnA) and aconitate 
hydrotase 2 (acrzB) (Figure 1) (74, 92, 93, 140, 141). Both catalyze the reversible isomerization of 
citrate and isocitrate via cis-aconitate and contain a labile iron-sulfur cluster (74, 140, 141). The main 
role of the aconitate hydrotase 1 enzyme is one of a maintenance or survival enzyme during nutritional 
or oxidative stress and it is inhibited byN03- by an unknown mechanism (140). The aconitate 
hydrotase 2 enzyme fimctions as the main catabolic enzyme ( 141 ). 
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Next, isocitrate dehydrogenase (icdA) converts isocitrate to a-ketoglutarate (Figure 1) (74, 92, 
l 42). Nicotinamide adenine dinucleotide phosphate (NADP1 is reduced to NADPH and C02 is 
generated in the reaction (74, 142). lsocitrate dehydrogenase was the first bacterial enzyme shown to 
be regulated by phosphorylation/dephosphorylation (74, 142). The enzyme is inactivated by 
phosphorylation which also affects the binding of NADP+ (7 4, 142). 
The enzymes encoded by the three genes, sucA, sucB, and lpdA, are required for the 2-
oxoglutarate dehydrogenase complex (Figure 1) (74, 92, 143). The substrate, a-ketoglutarate, is 
channeled through the catalytic reactions via a classical swinging arm carrying the substrate molecules 
to each successive active site (74, 143). The final products are succinyl-CoA and C02 (74, 143). 
NAD+ is also reduced to NADH (74, 143). 
Succinyl-CoA synthetase next catalyzes the reaction which yields succinate, coenzyme A and 
ATP from succinyl-CoA (Figure 1) (74, 144). This tetrameric enzyme contains two a-subunits (sucD) 
and two 13-subunits (sucC) (74, 92, 144). This is the only reaction in the TCA cycle that employs 
substrate-level phosphorylation (74, 144). 
Succinate is subsequently converted to fumarate by succinate dehydrogenase (Figure 1) (7 4, 
145). Succinate dehydrogenase is encoded by four genes: the sdhA gene encodes a flavoprotein 
subunit containing a covalently bound flavin adenine dinucleotide (FAD) moiety, the sdhB gene 
encodes an iron-sulfur protein; the sdh.C and sdhD genes encode two very hydrophobic membrane 
proteins which serve to anchor the hydrophilic flavoprotein and iron-sulfur protein subunits to the 
cytoplasmic membrane and also participate in electron transport (74, 92, 145). Succinate 
dehydrogenase is made llllder aerobic conditions and FAD is also temporarily reduced to F ADH2 
during the reaction (74, 145). Enzyme synthesis is regulated by catabolite repression (74). Activation 
of the enzyme by covalent attachment of FAD to the SdhA enzyme subunit is promoted by 
intermediates of the TCA cycle (74). 
S. typhimurium contains three distinct fumarases, encoded by the fumA.,fumB, andfumC 
genes, which all convert fumarate to malate (Figure 1) (7 4, 92, 146-148). The cell adapts to changing 
environmental oxygen concentrations by utilizing different isozymes (7 4, 146-148). Fumarase A is the 
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major active enzyme under microaerophillic conditions (1to2% oxygen) and is constitutively 
synthesized tlllder fermentation and microaerophillic conditions ( 146). Fumarase B also has some 
activity under microaerophillic conditions ( 14 7). Both fumarase A and fumarase B decrease activity 
when oxygen levels are greater than 15% (146, 147). Fumarase C is highly active under aerobic 
conditions (21% oxygen) (148). This provides the cell with an active fumarase tmder highly oxidative 
conditions (>4% oxygen), a situation where fumarase A is inactivated (146, 148). 
The last reaction in the TCA cycle is the conversion of malate to oxaloacetate by the dimeric 
enzyme malate dehydrogenase (mdh) (Figure 1) (74, 92, 149). Enzyme synthesis is subject to 
catabolite repression and is co-regulated withfumA; mdh andfamA have a common catabolite 
repressor protein (CRP) binding site upstream (149). NADH is an allosteric inhibitor of malate 
dehydrogenase (149). NAD+ is also reduced to NADH in this final reaction in the TCA cycle (149). 
The glyoxylate bypass in S. typhimurium is an inducible anapleurotic pathway within the 
TCA cycle required for growth on carbon sources such as acetate or fatty acids (74, 137, 138). This 
pathway allows the net conversion ofacetyl-CoA to metabolic intermediates (74). Strains lacking this 
pathway fail to grow on these carbon sources since acetate carbon entering the TCA cycle is 
quantitatively lost as C02 with no means to replenish the TCA precursor metabolites consumed for 
amino acid and heme biosynthesis (Figure 1) ( 68, 69, 7 4 ). 
The first enzyme in the glyoxylate bypass is isocitrate lyase (aceA), which catalyzes the 
conversion of isocitrate to glyoxylate and succinate (Figure 1) (7 4, 92, 150). lsocitrate lyase is 
activated by phosphorylation and inhibited by Ca2+, cC, oxalate, cis-aconitate, 3-phosphoglycerate, 2-
oxoglutatate, phospho( enol)pyruvate, succinate, glycolate, methylmalonate, and hydroxymalonate 
(150). Isocitrate lyase competes with the TCA cycle enzyme, isocitrate dehydrogenase, for isocitrate 
(7 4 ). Another enzyme, isocitrate dehydrogenase kinase/phosphatase ( aceK), is needed to decrease the 
activity ofisocitrate dehydrogenase to allow isocitrate lyase to effectively compete for isocitrate (74, 
92, 151 ). The second enzyme in the glyoxylate bypass is malate synthase A ( aceB), which catalyzes 
the conversion of glyoxylate plus acetyl-CoA to malate and coenzyme A (74, 92, 152). Malate 
synthase A is induced by growth on acetate and repressed by most other carbon sources (152). 
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Ins. typhimurium, isocitrate dehydrogenase (icdA) is regulated by phosphorylation; the 
function of this phosphorylation is to control the flow of isocitrate through the glyoxylate bypass 
(Figure 1) (74, 92, 142). During growth on acetate, approximately 75% of the isocitrate 
dehydrogenase is converted to the inactive phosphorylated form by isocitrate dehydrogenase 
kinase/phosphatase (74, 151). Inhibition of the isocitrate dehydrogenase slows the TCA cycle and this 
forces isocitrate through the glyoxylate bypass (74, 151). Although the glyoxylate bypass can provide 
metabolic intermediates, the TCA cycle is more efficient at generating energy (74). The cell must, 
therefore, precisely balances the flux of isocitrate between these two competing pathways during 
growth on acetate; the energy requirements of the cell appear to be monitored through AMP levels 
(74). AMP activates the phosphatase moiety and inhibits the kinase moiety ofisocitrate 
dehydrogenase kinase/phosphatase (7 4, 151 ). Isocitrate dehydrogenase kinase/phosphatase also 
controls the glyoxylate bypass during transitions between carbon sources (74, 151). 
The genes which encode the metabolic and regulatory enzymes of the glyoxylate bypass 
reside in the same operon, aceBAK, containing a single promoter (74, 92, 150-152). The operon is 
regulated by a repressor encoded by the ic!R gene (7 4, 138). Derepression of the aceBAK operon 
occurs upon adaptation to growth on acetate or fatty acids, presumably involving some metabolic 
intermediate; FadR arepressor of fatty acid degradation, mediates a part of the derepression process 
when the substrate is a fatty acid (74, 138). Expression of th~ operon is also upregulated by the 
histone-like protein, IHF (7 4 ). 
The pentose phosphate pathway. In addition to the formation of the precursor metabolites, 
ribose-5-phosphate and erythrose-4-phosphate, the pentose phosphate pathway may be required to 
provide NADPH for biosynthesis and survival within phagocytic cells (Figure 1) (57, 68, 69, 73). 
Another fimction of this pathway is the loog route between glucose-6-phosphate to fructose-6-
phosphate; this would effectively be a cycle for the complete oxidation ofhexose monophosphate to 
c~ (73). The pentose phosphate pathway is also needed for growth on pentoses and for the portion of 
gluconate metabolism not utilizing the Entner-Doudoroffpathway (73). 
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The pentose phosphate pathway in S. typhirrmrium utilizes the following enzymes (genes): 
glucose-6-phosphate dehydrogenase (zwf), 6-phosphogluconolactonase (pgl), gluconate-6-phosphate 
dehydrogenase (gnd), ribosephosphate isomerase (rpiA), ribose-5-phosphate isomerase (rpiB), D-
ribulose-5-phosphate 3-epimerase (rpe), transketolase 2 (tktB), transketolase 1 (tktA), transaldolase A 
(ta/A), and transaldolase B (talB) (Figure 1) (92, 93, 153-163). 
The Entner-Doudoroff pathway. The inducible Entner-Doudoroff pathway in S. 
typhimurium is employed for the metabolism of gluconate (73). The Entner-Doudoroff pathway can 
be properly considered as one of three pathways found in nature, in addition to the Embden-Meyerhof-
Parnas and pentose phosphate pathways, that feed into the "bottom half' of glycolysis, which is central 
to all intermediary metabolism (Figure 1) (164). 
Two gluconokinases, thermosensitive D-gluconate kinase (idnK) and gluconate kinase 2 
(gntK), plus ATP phosphorylates gluconate and yield gluconate-6-phosphate (Figure 1) (73, 93, 165, 
166). Gluconate-6-phosphate is converted to 2-keto-3-deoxy-gluconate-6-phosphate (KDPG) by 6-
phosphogluconate dehydratase (edd) (73, 164, 167, 168). The final step in the Entner-Doudoroff 
pathway is the conversion ofKDPG into glyceraldehyde-3-phosphate and pyruvate by 2-keto-3-deoxy-
gluconate-6-phosphate aldolase (eda) (73, 169, 170). The eda gene encodes for a multifunctional 
enzyme: 2-keyto-4-hydroxyglutarate aldolase participates in the regulation of intracellular levels of 
glyoxylate and oxaloacetate decarboxylase activity participates in the dissimilation of glyoxylate to 
pyruvate (169, 170). Competitive inhibitors include glyceraldehyde-3-phosphate and gluconate-6-
phosphate ( 169). The edd-eda operon is repressed by GntR and is induced ( derepression of GntR) by 
gluconate, although a high basal expression of eda occurs regardless of the carbon source (92, 164, 
171). 
The fatty acid (3-oxidation pathway. Although enzymes in the aerobic fatty acid J3-
oxidation pathway degrade both long and short chain fatty acids, it is the long chain compounds that 
induce the enzymes of this pathway (172). The first step in fatty acid degradation is the activation of 
the free fatty acid to an acyl-CoA thioester by acyl-CoA synthetase ifadD) (Figure 1) (93, 172, 173) 
This initial activation step requires coenzyme A (CoA-SH) and two high-energy phosphate equivalents 
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from ATP per molecule of fatty acid (173). Each turn of the cycle yields an acetyl-CoA, an NADH, 
and an F ADH2 (172, 173). The cycle utilizes the enzymes acyl-CoA dehydrogenase (yafe/), cis-~3-
trans-~2-enoyl-CoA isomerase ifadB), enoyl-CoA hydratase ifadB), 3-hydroxyacyl-CoA epimerase 
ifadB), 3-hydroxyacyl-CoA dehydrogenase (fadB), and 3-ketoacyl-CoA thiolase (fadA) (92, 173, 174-
l 76). One of the products of J3-oxidation, acetyl-CoA, is fed into the TCA cycle and glyoxylate 
bypass, which facilitates its conversion to metabolic intermediates (74, 137, 173). The reducing 
equivalents produced, NADH and F ADH2, can be regenerated in the electron transport chain producing 
ATP via oxidative phosphorylation (131, 133, 134, 173). 
When even numbered fatty acids are broken down, a two carbon compound remains, acetyl-
CoA ( 172). When odd numbered fatty acids are broken down, a three carbon compound remains, 
propionyl-CoA; this is further catabolized by the reactions of propionate catabolism (172). 
Unsaturated fatty acids require additional metabolic reactions by an isomerase, an epimerase, and a 
reductase reactions to enter the acid J3-oxidation pathway ( 172). Expression of the genes of the J3-
oxidation pathway are usually subjected to strong catabolite repression (173). ThefadBA operon also 
is negatively regulated by the FadR repressor; acyl-CoA relieves this repression (173). 
Fructose catabolism. The same general PTS system as glucose is utilized by fructose for 
entry into the cell; fructose is simultaneously transported and phosphorylated by group translocation 
(73, 90). The general PTS proteins, EI (ptsll) and Hpr (ptsl) are the soluble cytoplasmic proteins that 
participate in the phosphorylation of all PTS carbohydrates (Figure 1) (90-92). The Ellfru enzyme 
complex ifru.A,fruB) is fructose-specific, possesses three domains in the FruA protein (IIB'-IIB-IIC) 
and three domains in the FruB protein (IIA-IIM-IIH) (91, 93, 177, 178). Domains IIA-IIB-IIB' are 
localized to the cytoplasmic side of the membrane (177, 178). The domain IIB' is required for high 
affinity binding ofFruB to FruA, but does not participate in phosphoryl transfer (177, 178). Domain 
IIA is the first phosphorylation site, IIM is a central domain of unknown function, and IIH is an HPr-
like domain called FPr (fructose-inducible HPr) (177, 178). Fructose-I-phosphate is the product of 
this series of reactions (91, 177, 178). 
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Fructose- I-phosphate kinase (fruK) converts fructose- I-phosphate to fructose- I,6-
bisphosphate in a reaction which requires ATP or GTP; the product enters the glycolytic (EMP) 
pathway (9I, 92, I 79). Fructose-I-phoshate kinase is reversibly inhibited by fructose-I,6-bisphosphate 
and ADP (179). 
The fructose operon ifruBKA) is subject to positive control by the cAMP/cAMP receptor 
protein (CRP) complex (9I, I 77, I 78). The era gene, formerly thefru.R gene (fructose repressor), 
encodes a Cra (catabolite repressor/activator) repressor protein of the fructose operon; era does not 
mapnearthejruBKAoperon(9I, I77, I78). 
Growth of S. typhimurium utilizing a non-limiting glucose source. The branched, 
biosynthetic form of the TCA cycle utilizing a non-limiting glucose source was separated from the 
above pathways because of its importance to this study. The TCA cycle is split into a oxidative branch 
terminating at a-ketoglutarate and a reductive branch terminating at succinyl-CoA (Figure 2) (74, 78). 
The oxidative branch functions as described in the section above titled: The TCA cycle and glyoxylate 
bypass. However, the reductive branch of the TCA cycle functions backwards utilizing the same 
reversible enzymes except succinate dehydrogenase (sdhCDAB), which is replaced by fumarate 
reductase (frdABCD)(14, 78, 93, I80). 
Fumarate reductase is composed of four subllllits and two domains (I80). The catalytic 
domain consists of two subunits: one with a covalently-bound flavin cofactor and the fumarate binding 
site; the other contains three iron-sulfur clusters (I80). This catalytic domain is attached to the 
cytoplasmic side of the cytoplasmic membrane by the anchor domain, which consists of two subunits 
that interact with quinone and contain heme (180). The enzyme also has two quinol-binding sites, Qp 
and ~ (180). The covalent attachment of FAD to the enzyme (A subunit apoprotein) is stimulated by 
citrate, isocitrate, succinate, and fumarate , acting as possible allosteric effectors (I 80). Fumarate 
reductase is inhibited by oxaloacetate and malonate (180). 
Oxaloacetate is converted to aspartate by aspartate aminotransferase ( aspC) in this branched, 
biosynthetic form of the TCA cycle (Figure 2) (74, 93, I8I). Glutamate is also a rea:ctant and 2-
oxoglutarate a product of this reaction (I 8 I). The dimeric aspartate aminotransferase enzyme is 
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inhibited by 2-methyl aspartate (181). Aspartate ammonia lyase (aspA) next converts aspartate to 
fumarate and NH3 (74, 92, 182). Aspartate ammonia lyase is activated by aspartate and inhibited by 
citrate and n-propanol (182). 
Tue full TCA cycle is not required for growth of S. typhimurium utilizing a non-limiting 
glucose source because the bulk of energy is derived from glycolysis (7 4, 78). In this glucose-rich 
environment, cells produce excess acetyl-CoA which drains through acetyl phosphate, to further 
produce ATP with the associated secretion of acetate (Figure 2) (78, 79). As cell density increases, the 
build-up of acetate also serves to increase the size of the acetyl phosphate pool (78). 
Regulation by catabolite repression. Catabolite repression is often called the glucose effect 
because glucose, which yields the highest return of ATP per unit of expended energy, usually strongly 
represses operons for the utilization of other carbon sources (183). Catabolite repression in S. 
typhimurium involves the cytoplasmic sensor of carbon and energy concentrations, cAMP, and the 
dimeric CRP protein; cAMP binds to CRP at specific DNA sequences in cAMP-CRP-sensitive 
promoters, induces bends in the DNA, and interacts with RNA polymerase to promote transcriptional 
initiation (184, 185). However, the mechanism of cAMP-CRP regulation varies; CRP can fimction not 
only as an activator, but also as a repressor depending where it binds relative to the promoter (184, 
185). 
The synthesis of cAMP is controlled through the regulation of activity of adenylate cyclase 
(186). This enzyme, which catalyzes the formation of cAMP from ATP, is more active when cellular 
concentrations of catabolites are low and less active when catabolite concentrations are high ( 186). 
The synthesis of cAMP is regulated by a protein phosphorylation mechanism that is catalyzed by the 
PTS system (184). PTS penneases fimction as transmembrane signal transduction devices: when one 
of the PTS sugars (i.e. glucose, fructose, mannitol) such as glucose is present extracellularly, the crr-
encoded enzyme IIA Glc protein becomes dephosphorylated as the phosphoryl groups are transferred to 
incoming sugar molecules via the sugar-specific permease proteins (91, 94, 184). This process results 
in both allosteric deactivation of adenylate cyclase, allosteric inhibition of the non-PTS permeases (ie. 
lactose, maltose, and glycerol permeases ), and catabolic enzymes that generate cytoplasmic inducers 
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(91 , 184). Exogenous glucose both inhibits the synthesis of cAMP and stimulates the efllux of cAMP 
from the cell cytoplasm (184). 
Almost all genes that encode enzymes and transport proteins which initiate the metabolism of 
an exogenous carbon source are tlllder cAMP-CRP control; the expression of the genes is consequently 
subject to catabolite repression (184). The levels of the TCA cycle enzymes are regulated at the 
transcriptional level by catabolite repression (136). Phospho(enol)pyruvate carboxylase (ppc) is tlllder 
cAMP control an well ( 184 ). One of the primary responses to a limitation of a specific nutrient is the 
activation of the cAMP-CRP regulon; this allows higher-affinity uptake of the nutrient present in low 
concentration or the utilization of an alternative carbon source ( 187). 
Many proteins in addition to carbon catabolic enzymes have been shown to be subject to 
catabolite repression (183). Flagellar synthesis, as well as chemotaxis are subject to cAMP control 
(184). Finally, genes involved in pH regulation, extracellular macromolecule degradation, ubiquinone 
synthesis, intracellular glycogen metabolism, nitrogen utilization, organic phosphate ester utilization, 
thiolsulfate reduction, iron uptake, drug (antibiotic) resistance, colicin induction and recognition, and 
toxin production are all regulated directly or indirectly by cAMP-CRP (184). Many of these processes 
are related to carbon metabolism (184). 
Regulation of central carbohydrate metabolism via the csrA gene. The carbon storage 
regulator gene, csr A, exhibits pleiotropic regulation of central Carbohydrate metabolism in E. coli (82). 
The regulatory effects of Csr A peak during the transition from exponential phase into early stationary 
phase (82). The CsrA regulatory protein dramatically affects the biosynthesis of glycogen through its 
negative control of two glycogen genes, glgC (ADP-glucose pyrophosphorylase) and glgB (glycogen 
branching enzyme) (82). Intracellular carbon flux is also directed by CsrA in both the glycolytic (EMP 
pathway) and gluconeogenic pathways (82). CsrA exerts negative regulation of gluconeogenesis with 
a decrease in the specific activity of phospho( enol)pyruvate carboxykinase (pckA.), 
phospho(enol)pyruvate synthetase (pps), and fructoste-1,6-bisphosphatase (jbp) (Figure 1) (82). 
Positive regulation of glycolysis by CsrA is reported in the increased specific activity of 
glucosephosphate isomerase (pgi), 6-phosphofructokinase-I (pjkA), triose phosphate isomerase (tpi), 
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enolase ( eno ), and pyruvate kinase I (pykF) (82). In contrast, the expression of genes in the pentose 
phosphate pathway is weakly or negligibly affected by CsrA (82). S. typhimurium possesses a nearly 
identical homologue of this csr A gene (92, 188). 
Regulation of central carbohydrate metabolism by the ArcA-ArcB two-component 
signal transduction system. The two component regulatory ArcA-ArcB system functions as a major 
control system for the regulation of expression of genes encoding enzymes in both aerobic and 
anaerobic catabolic pathways (189, 190). Over forty operons are controlled by the ArcA-ArcB system 
(189). Almost all of the genes of the TCA cycle and glyoxylate shllllt are subjected to repression by 
the ArcA-ArcB two component regulatory system (Figure 1) (191). The exception is the sdhCDAB-
sucABCD operon, containing five ArcA binding sites, which is primarily initiated and regulated at the 
upstream sdh promoter (192). ArcA positively regulates this operon at the two upstream ArcA binding 
sites and represses the operon at the remaining ArcA binding sites flanking or within the sdh promoter 
(192). This operon also contains one internal promoter' p sue (192). 
The expression of Arc-regulated genes varies in response to environmental 0 2, although this 
compound is not thought to be the signal detected by the ArcB sensory kinase (190, 193). ArcB 
probably senses the redox state of the cell through the detection of an electron transport component in 
reduced form (189, 193). The phosphorylated form of the response regulator ArcA (ArcA-P) is 
predicted to reach peak levels in anoxic cells as the ArcB kinase activity progressively increases dming 
the transition from aerobic to anaerobkgrowth (193). However, significant levels of ArcA-P are 
apparent in aerobic cells, and differential patterns of expression of the members of the ArcA modulon 
can be attributed, at least in part, to the affinity of ArcA-P for DNA binding sites located in the 
transcriptional regulatory regions of its targeted operons (193). 
ArcA plays a vital role in adjusting catabolism to oxygen-restricted growth conditions through 
regulation of carbon flux via the TCA cycle and electron flux via terminal cytochrome oxidases, rather 
than to adjust catabolism to fully aerobic or anaerobic conditions (189). Studies of the intracellular 
redox state (NAD+ /NADH) tlllder varying Di concentrations, of an ArcK mutant, strongly suggest that 
ArcA is actually a microaerobic redox regulator ( 189). 
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Acetyl phosphate and the activation of two-component signal transduction systems. It 
has been estimated that there may be as many as fifty different two-component signal transduction 
systems in E. coli (24 ). Acetyl phosphate has bee? shown to phosphorylate numerous response 
regulator proteins in vitro and has been shown to influence several two-component signal transduction 
pathways in vivo (25, 190). Studies have shown that a major secondary source ofphosphoryl groups is 
from a small molecule phospho-donor, acetyl phosphate (79). When E. coli is incubated with acetyl 
phosphate, the following response regulator protein components of two-component signal transduction 
systems, become phosphorylated: CheB, NtrC, PhoB, OmpR, and ArcA (24, 79). These 
phosphorylated response regulator proteins control the expression of genes or operons involved in 
chemotaxis, nitrogen regulation, phosphate-specific transport systems, outer membrane proteins 
involved in osmo-regulation, and enzymes in both aerobic and anaerobic catabolic pathways 
respectively (24, 79, 189, 190). 
The demonstration that acetyl phosphate can serve as a substrate for response regulator 
autophosphorylation revealed some subtle aspects of the two-component signal transduction pathways 
(24). These pathways can be regulated by controlling the levels ofphospho-donors, phospho-histidine 
kinases, or by controlling the rates of dephosphorylation of the active response regulators (24 ). 
The function of acetyl phosphate in two-component signal transduction systems may be to 
adjust the sensitivity and/or the magnitude of an adaptive response such as shifts in metabolism and 
transitions in the expression of virulence factors (79). If acetyl phosphate contributes to the basal 
levels of phospho-response regulators within a cell, then higher levels of acetyl phosphate would 
produce a more sensitive system; a smaller stimulus would be required to produce enough 
phosphorylated response regulator to trigger a response (79). 
Salmonella vaccines and vaccine candidates. Two Salmonella typhi vaccines, the live oral 
S. typhi Ty21 a and a vaccine based on the Vi polysaccharide capsule of S. typhi, currently are licensed 
in several countries ( 194 ). The S. typhi Ty21 a is a galactose epimerase (galE) mutant: the galactose 
required for the synthesis of smooth LPS 0 antigen is derived from UDP-galactose, which is 
synthesized from UDP-glucose by the enzyme galactose epimerase (195). The result is an avirulent 
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strain with rough LPS (195). This property, coupled with the fact that S. typhi Ty2la is also Vi antigen 
negative, is a factor in the safety of this live vaccine strain in vivo (195). The Vi antigen, a capsular 
polysaccharide composed of N-acetylglucosamine, is produced by the most virulent S. typhi strains 
(l96). Each of the above vaccines, while effective, still suffers from drawbacks such as fevers after 
administration, incomplete protection, and a loss of protection with time (194, 195). Therefore, new 
attenuated S. typhi live oral vaccines are being developed (194, 195). 
Live oral typhoid fever vaccine candidates, based on deletions in genes necessary for 
Salmonella pathogenesis, have shown progress (197, 198). For example, the live oral S. typhimurium 
~c.ya (adenylate cyclase) fl.crp (cAMP receptor protein) vaccine is based on deletions in a global 
regulatory system and is effective in animals and humans (197, 198). The live oral S. typhi fl.eya ~crp 
vaccine becomes even more effective when a third deletion in the cdt gene (deep tissue colonization) is 
introduced (199, 200). 
Another typhoid fever live oral vaccine, avirulent and imnumogenic in mice and cattle, is 
based on aroC and aroD deletions in S. typhimurium; this strain is auxotrophic for aromatic 
compounds which are unavailable in mammalian cells (198, 201, 202). This ~aroC and fl.aroD double 
mutant is unable to synthesize chorismic acid, a precursor of the aromatic compounds p-aminobenzoic 
acid and 2,3-dihydroxybenzoate, and no other pathway for their synthesis exists in S. typhimurium 
(198, 201). As a consequence of this auxotrophy, the bacteria Cannot proliferate within mammalian 
cells, yet they reside and replicate long enough to stimulate protective immune responses (198, 201, 
202). Again, the introduction of a third deletion in the htrA gene (a protease 00 precursor heat shock 
protein) in a S. typhi strain increase the effectiveness of this vaccine candidate in clinical trials (54, 
199, 200). 
Another live oral typhoid fever vaccine candidate, based on deletions in genes of the phoP-
phoQ two-component signal transduction system (regulation of virulence genes), is avirulent and 
immunogenic in mice and humans (200, 203, 204). A recent Salmonella enterica serovar 
Typhimurium live oral vaccine contains a deletion in the DNA adenine methylase (dam) gene (205). 
DNA adenine methylase plays an important role in the timing and targeting of a number of cellular 
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functions including DNA replicatio~ segregation of chromosomal DNA, and mismatch DNA repair 
(6 l). The Uun-vaccine strain was avirulent in day-of-hatch chicks (broiler chickens) and elicited 
cross protective immune responses against challenge by homologous serovars ofTyphimurhnn and 
heterologous serovars ofEnteritidis (205, 206). The vaccine strain also proved to be highly attenuated 
for virulence in mice and conferred protection against murine typhoid fever (206). 
The use of attenuated Salmonella strains as live vaccines is a safe and effective means of 
inducing significant humoral and secretory antibody responses in animal species humans, cattle, 
sheep, rabbits, fowl, and mice (195). Live Salmonella invade the Peyer's patches, where they present 
their numerous antigens directly to the T and B lymphocytes of the mucosal-associated lymphoid 
tissues (195). This elicits the mucosal immune system to produce antigen-specific immune responses 
(195). Due to the significant humoral and secretory antibody responses, live attenuated Salmonella 
strains show great promise for carriers of antigenic determinants from other pathogenic 
microorganisms (195, 200). 
Other S. typhimurium strains attenuated for virulence. A strain of S. typhimurium, with a 
mutation inptsH-encoded enzyme I (El) of the phospho(enol)pyruvate: sugar phosphotransferase 
system (PTS), has been reported as attenuated for virulence in an intraperitoneal mouse model; the log 
(attenuation) values were 2.3 below the wild-type Salmonella strain (90-92, 207). The general PTS 
proteins, EI and HPr, transfer phosphoryl groups from phospho(enol)pyruvate the sugar-specific 
transporters (Ellsu~ in the PTS system (91, 207). The PfS system is also an integral part of cAMP-
CRP regulation (catabolite repression) and the genes of its regulon (183-185). 
The outer membrane of S. typhimurium contains LPS; lipid A is the major component of this 
endotoxin that stimulates inflammatory cytokine release and inducible nitric oxide synthase (iNOS) 
responses in the murine host (7-9, 22, 208). AS. typhimurium strain with a deletion in the waaN gene, 
which encodes the enzyme that catalyzes one of the two secondary acylation reactions that complete 
lipid A biosynthesis, was constructed (9). The waaN mutant strain, which synthesize a full-length 
LPS molecule containing the O antigen and lack only the secondary acyl chain, were intravenously 
injected into BALB/c mice at a dose of with 102 bacteria per mouse (9). Extremely high bacterial 
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counts of 109 in the liver and spleen were observed (the lethal load of the wild-type parental strain is 
10s bacteria per organ), and only approximately 10% of the mice expired (9). Most of the remaining 
mice carrying these extremely high waaN mutant bacterial loads recovered and eventually cleared the 
bacteria from the organs (9). lhls study implied that death in a mouse typhoid infection is directly 
dependent on the toxicity of lipid A and suggested that this is mediated via pro-inflammatory cytokine 
and/or the iNOS responses (9). 
The Vaccine Candidate Salmonella typhimurium SR-11 Fad-. The live oral vaccine 
candidate, Salmonella typhimurium SR-11 Fad-, was constructed by TnJ Od: :cam transposon 
mutagenesis of the SR-11 parent strain (209, 210). The mutant strain was selected for its inability to 
catabolize oleate and citrate as sole carbon sources (210). It was phenotypically designated Fad- (Fatty 
acid) for its inability to catabolize fatty acids as a sole carbon source (210). The SR-11 Fad- strain also 
was unable to utilize acetate and isocitrate as carbon sources, but could utilize glucose, and glycerol 
(210). 
The disease caused by Salmonella typhimurium in mice mimics typhoid fever in humans and 
is well accepted as a model for human typhoid (20, 21). Salmonella typhimurium SR-11 Fad-, 
administered peroraly, was completely avirulent in BALB/c mice at a dose as high as 109 colony 
forming units ( cfu) (210). In contrast, the SR-11 parent strain proved lethal at doses of greater than 104 
cfu (210). The vaccine candidate also was found to be protective in BALB/c mice (33, 210) as well as 
avirulent and protective in chickens (Dr~ Paul S. Cohen: personal communication). A single oral dose 
of 10 7 SR-11 Fad- cells protected BALB/c mice against a lethal dose of 109 cells of the virulent SR-11 
S. typhimurium parent strain (33, 210). 
The S. typhimurium SR-11 Fad- strain was also found to be slightly attenuated relative to the 
SR-11 wild-type parental strain when administered intraperitoneally: 100% of the BALB/c mice 
survived an intraperitoneal injection of 5 x 101 SR-11 Fad- bacteria whereas 1000/o of the BALB/c mice 
were killed by the same dosage ofSR-11 wild-type cells (210). However, only 50% of the BALB/c 
mice survived an intraperitoneal injection of 1.5 x 102 SR-11 Faci- bacteria and 100% mortality was 
observed in doses greater than 1.5 x 103 cells (210). 
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Attenuated strains of Salmonella generally exhibit higher virulence with intraperitoneal 
injection versus peroral inoculation; this mmatural route for Salmonella infection bypasses the M cells 
(filled with a cluster ofB cells, T cells, and macrophages) and the mucosal-associated lymphoid tissue 
carrying intraepithelial lymphocytes (T-cells which express unusual T-cell receptors and exhibit 
limited diversity for antigens), the lamina propria, (large numbers of B cells, plasma cells, activated 
helper-T cells, and macrophages in loose clusters), and the Peyer's patches (nodules consisting of30-
40 organized lymphoid follicles) (11, 21, 29, 30, 33, 34). 
SR-11 Fad- is a era (fruR) mutant. Southern hybridization with a probe specific for the 
chloramphenicol resistant cassette in SR-11 Fad-, followed by cloning of a 4.5 kb Pst I fragment 
containing the mini-TnlOd::cam into pBluescript II SK(+) yielded the plasmid pJHA7 (33). 
Sequencing of pJHA 7 revealed the gene interrupted by the mini-transposon was the era gene (33). 
Furthermore, complementation with a wild-type era gene in the plasmid pJHA8 (Table 1) restored 
both virulence in BALB/c mice as well as the ability of SR-11 Fad- to utilize fatty acids and 
gluconeogenic substrates as sole carbon sources (33, 211). 
The Cra protein: a global regulator of carbon and energy metabolism in glycolysis and 
gluconeogenesis. In E.coli and S. typhimurium the era gene (catabolite repressor/activator), formerly 
the.fro.R gene, encodes the 150 kDa homotetrameric DNA-binding Cra protein (212). The Cra protein, 
a global regulator of carbon and energy metabolism in glycolysis and gluconeogenesis, represses 
transcription of genes encoding glycolytic enzymes {specific enzymes in the EMP and Entner-
Doudoroff pathways) but activates transcription of genes encoding enzymes involved in biosynthesis 
(specific enzymes in the TCA cycle, the glyoxylate shtmt, and the gluconeogenic pathway) (Figure 3) 
(213-217). 
The Cra protein recognizes an imperfect palindromic DNA sequence (TGAA, A or T, C • C 
or G, any nucleotide, T, A or C, A or C, A or T) which it binds to asymmetrically (217). Ifthe Cra 
binding site is upstream of the promoter, it activates transcription of the target operon or gene; ifit 
overlaps or is downstream of the promoter, Cra represses transcription of the target operon or gene 
(217). Transcription of at least 20 genes is upregulated up to ten-fold and downregulated by a 
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maximum of eleven-fold by the Cra protein (214, 217, 218). The Cra protein acts independently of 
cAMP-CRP transcriptional regulation (catabolite repression) (217, 219, 220). Two effector molecules 
of the era protein, µM concentrations of fructose- I-phosphate and mM concentrations of fructose-1,6-
bisphosphate, inactivate the DNA-binding protein (Figure 4) (212, 217, 219, 221). Therefore, growth 
on glucose or fructose may inactivate the Cra DNA-binding protein via these two effectors (222, 223). 
Derepression of the glycolytic pathway and deactivation of the gluconeogenic pathway by the effectors 
of era also help to ensure the preferential utilization of carbon sources such as glucose and fructose 
(223). 
The Cra global regulatory protein also represses the pts operon: ptsH (PTS general enzyme 
El), ptsl (PIS general enzyme Hpr), and err (glucose specific enzyme IIA Glc) constitute the pts operon 
(Figure 3) (90, 91, 94, 212, 215, 222). Cra (FruR) mutants were first isolated as suppressor mutations 
which allowed ptsH mutants to grow on PTS carbohydrates; the suppression resulting from the 
constitutive synthesis of the HPr-like domain ofthefruB-encoded diphosphoryl transfer protein 
because it can substitute for HPr (212). Furthermore, data has shown that llllder certain physiological 
conditions, Cra modulates the activity of adenylate cyclase, the cAMP biosynthetic enzyme (217). 
Since the PTS system is also an integral part of cAMP-CRP regulation ( catabolite repression), the 
global regulator Cra is intertwined with other global regulators that exert pleiotropic effects on the 
transcription of operons and genes involved in central carbon ID:etabolism (72, 73, 183-185, 217). 
The catabolite repressor/activator Cra protein was initially characterized as the fructose 
repressor (FruR: fructose repressor) (217). Cra is a transcriptional repressor ofthefruB(F)KA operon: 
fruA andfruB encoding the Ellrru enzyme complex of the PTS system andfruK. encoding fructose-1-
phoshate kinase (Figure 3) ( 177-179, 212, 224, 225). S. typhimurium and E. coli mutants defective in 
the era ifruR) gene are unable to grow on gluconeogenic substrates such as acetate, lactate, pyruvate, 
alanine, and all the TCA cycle intermediates, as sole carbon sources (212, 217, 218, 225). 
Cra has also been reported to repress the transcription the following operons or genes: adhE 
(the fermentative bi-fuctional enzyme ethanol dehydrogenase), epd (gapB) (a component of the 
erythrose-4-phosphate dehydrogenase enzyme which plays a role in the de novo biosynthesis of the 
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pyridoxal-5'-phosphate coenzyme), nirBD (nitrate reductase enzyme) and mtlADR (mannitol transport 
proteins and catabolism enzymes) (92, 219, 221, 223, 227-230). 
The goal of this study. The initial goal of this study was to determine the extent to which 
gluconeogenesis is linked to virulence and pathogenesis in S. typhimurium SR-11, since S. 
typhimurium SR-11 Fad-, is unable to l.llldergo gluconeogenesis and is avirulent in BALB/c mice (33, 
210). To that end, the construction of several mutations in the gluconeogenic pathway was planned to 
determine the virulence of these strains. A second goal of this study was to determine the regulation of 
the era gene by assaying for era promoter activity during growth on various gluconeogenic and 
glycolytic substrates and how deletions in the gluconoegenic pathway would the alter era promoter 
activity. 
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Materials and Methods 
Bacterial strains and plasmids. Bacterial strains and plasmids used in this study are listed in 
Table 1. 
Agarose gel electrophoresis. Agarose gels were made with a concentration of0.85% 
(wt/vol) of molecular biology grade agarose (Fisher Scientific, Fair Lawn, NJ) or DNA grade low melt 
agarose (Fisher Scientific, Fair Lawn, NJ) in TAE buffer (pH 8.5; 40 mM Tris-acetate; 1.0 mM EDTA; 
5 Prime~ 3 Prime, Inc., Boulder, CO) with ethidium bromide (Sigma Chemical Co., St. Louis, MO) at 
a final concentration of0.2-0.4 µg/ml (234). Three different DNA standard markers were used: a 100 
bp DNA Step Ladder (Promega Corporation, Madison, WI), a 1 kb DNA Step Ladder (Promega 
Corporation, Madison, WI) and a 1 kb DNA Ladder (Promega Corporation, Madison, WI). 
Agarose gel photography. Agarose gels were viewed on a Fotodyne ultra-violet 
transilhnninator (Fotodyne, Inc., New Berlin, WI) and photographed with a Kodak OC12 Zoom 
Digital Camera (Eastman Kodak Company, Rochester, NY) (235). Kodak J?igital Science lD software 
(version 3.0.2; Eastman Kodak Company, Rochester, NY) was used to analyze the digital photographs. 
Text and graphics were added with Adobe® Photoshop® (version 4.0 LE; Adobe Systems, Inc.). 
Antibiotics. Antibiotics were purchased from Sigma Chemical Co. (St. Louis, MO) and 
Fisher Scientific (Fair Lawn, NJ) and added to media at a final concentration, except where noted, as 
follows: 100 µg/ml or 150 µg/ml ampicil.lin; 30 µg/ml chloramphenicol; 40 µg/ml kanamycin 
monosulfate, 50 µg/ml nalidixic acid; 100 µg/ml streptomycin sulfate; and 10 µg/ml tetracycline 
hydrochloride. 
Bacterial growth media. Lillia broth (LB; Lennox formulation; Difeo Laboratories, Detroit, 
MI and Fisher Scientific, Fair Lawn, NJ) and Luria agar plates (Lennox formulation; Difeo 
Laboratories, Detroit, MI and Fisher Scientific, Fair Lawn, NJ) were used routinely unless noted. 
M9 minimal medium was adjusted to pH 7.0 ± 0.1 and separately supplemented with various 
glycolytic and gluconeogenic substrates (Sigma Chemical Co., St. Louis, MO and Fisher Scientific, 
Fair Lawn, NJ) at the following anhydrous concentrations: D-fructose (0.2% [wt/vol]), D-glucose 
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(0.2% [wt/vol]), D-gluconic acid potassium salt (0.2% [wt/vol]), glycerol (0.2% [vol/vol]), potassium 
acetate (0.4% [wt/vol]), D-alanine (0.2% [wt/vol]), soditnn citrate (0.2% [wt/vol]), fumaric acid 
disodium salt (0.4% [wt/vol]), L(-)malic acid (0.6% [wt/vol]), phospho( enol)pyruvate monosodium 
salt (0.4% [wt/vol]), pyruvic acid sodium salt (0.4% [wt/vol]), oleic acid sodium salt (5mM), and 
succinic acid disodium salt (0.6% [wt/vol]) (236). 
M9 minimal agar plates, containing 15 glL of noble agar (Difeo Laboratories, I>etroit, MI) 
and separately supplemented with the various glycolytic and gluconeogenic substrates, were utilized 
for determination of growth (utilization of substrate by the bacteria) (236). The M9 minimal agar 
plates were incubated at 37°C and the results were recorded at 24 hours and 48 hours. M9 minimal 
medium (broth) were used for determination of growth, rate of growth, and p-galactosidase assays (for 
a detailed protocol see "P-galactosidase assays for era promoter activity" in this section) (232, 233, 
236, 237). 
SOB medium contained 2% (wt/vol) Bacto™ tryptone (Difeo Laboratories, I>etroit, Ml), 
0.5% (wt/vol) yeast extract (Difeo Laboratories, I>etroit, Ml), 10 mM NaCl (Sigma Chemical Co., St. 
Louis, MO), 2.5 mM KCl (Sigma Chemical Co., St. Louis, MO), 10 mM MgC!i•6 H20 (Sigma 
Chemical Co., St. Louis, MO), and 10 mM MgS04•7 H20 (Sigma Chemical Co., St. Louis, MO) (238). 
SOC medium included SOB medium plus 20 mM glucose (238). Both SOB and SOC media were 
used in allelic replacement protocols where noted. 
Fusaric acid selection medium contained 1% (wt/vol) tryptone, 0.5 % (wt/vol) yeast extract, 
1 % (wt/vol) NaCl, 0.2% (wt/vol) D-glucose, 0.005% (wt/vol) chlorotetracycline HCl (Sigma Chemical 
Co., St. Louis, MO), 1% (wt/vol) Na2HP04 • H20 (Sigma Chemical Co., St. Louis, MO), 2% (wt/vol), 
100 µM ZnCl2 (Sigma Chemical Co., St. Louis, MO), and fusaric acid @ 20µg /ml (Sigma Chemical 
Co., St. Louis, MO) (239). 
All liquid bacterial cultures were grown overnight at 3 7°C, with aeration, in the appropriate 
antibiotic(s) except where noted. Agar plates were incubated at 37°C for 12-18 hours except where 
noted. MacConkey (Difeo Laboratories, I>etroit, MI) and XLD (Difeo Laboratories, I>etroit, MI) 
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selective and differential agar plates were used to characterize all transformants, transconjugants, and 
segregants. 
Isolation of genomic DNA. (Note: volume ofreagents used and/or centrifugation speed and 
time varied according to the initial volume of the bacterial cultures and/or bacterial strain (240)). 
Genomic DNA was isolated by a modified protocol from Current Protocols in Molecular Biology 
(241 ). Bacterial cells from an overnight culture were pelleted by centrifugation, resuspended in TE 
Buffer (10 mM Tris-HCI [Tris[hydroxymethyl]aminomethane hydrochloride]; 1 mM EDTA 
[ethylenediaminetetraacetic acid]; pH 8.0, (5 Prime~ 3 Prime, Inc., Boulder, CO), lysed with sodium 
dodecyl sulfate (SDS) (BioRad Laboratories, Richmond, CA), and incubated at 37°C for one hour in 
proteinase K (Sigma Chemical Co., St. Louis, MO) to degrade protein. Hexadecyltrimethylammonhnn 
bromide (100/o CTAB in 0.7 MNaCl) was added to the lysate and incubated at 65°C for 15 minutes. 
An equal volume of chloroform/isoamyl alcohol (24:1) (Sigma Chemical Co., St. Louis, MO) was 
added to the lysate. The aqueous phase, containing the DNA, was extracted after centrifugation. A 
second extraction with phenol/chloroform/isoamyl alcohol (25:24: 1) (Sigma Chemical Co., St. Louis, 
MO), removed residual CT AB precipitate. The DNA was precipitated in 100% isopropanol (Sigma 
Chemical Co., St. Louis, MO) and pelleted by centrifugation. The DNA pellet was rinsed in 70% 
ethanol to remove excess salt, lyophilized, and resuspended in 1E buffer. Incubation (37°C for greater 
than 1 hour) of the genomic DNA in RNase A (Sigma Chemical Co., St. Louis, MO) degraded most of 
the contaminating RNA. The DNA underwent a final phenoVchloroform/isoamyl extraction and 
precipitation in 100% ethanol to remove the RNase A and any residual proteins (242). 
Genomic DNA also was isolated by using the GNOME® genomic DNA isolation kit (BIO 
101, Vista, CA). The protocol from the manufacturer was modified by increasing the initial volume of 
overnight liquid bacterial cell culture to 10 ml per miniprep. The kit used a "Cell Suspension 
Solution," "RNase Mboc," "Cell Lysis/Denaturing Solution," "Protease Mixx," and "Salt-Out Mixture" 
of unspecified composition and replaced the chloroform steps of the standard protocol with incubation 
at 4°C followed by centrifugation (241). A final precipitation of the genomic DNA in 100% ethanol 
completed the manufacturer's protocol (242). 
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Genomic DNA also was isolated by using the Wizard® genomic DNA Prep Kit (Promega 
Corporation, Madison, WI). The manufacturer's protocol was followed using up to 3 ml of an 
overnight culture of bacteria. All centrifugation steps were performed at 14,000 x gin an Eppendorf 
microcentrifuge (#5415C; Brinkmann Instruments, Inc., Westbury, NY). The isolated genomic DNA 
was incubated in an excess of DNA rehydration solution (10 mMTris-HCl, pH 7.4; 1 mMEDTA, pH 
s.O) at 65°C for greater than one hour or a combination of incubation at 65°C followed by overnight 
incubation at room temperature. All genomic DNA was frozen at -20°C for short-term storage and 
_ 78°C for long-term storage. 
Isolation of plasmid DNA. Quantities of plasmid DNA greater than 10 µg were isolated by 
modified alkaline lysis (243). A minimtnn of 100 ml of bacterial cells from an overnight liquid culture 
were pelleted by centrifugation and resuspended in GTE Buffer ( 50 mM glucose; 10 mM EDT A 
[ ethylenediaminetetraacetic acid]; 25 mM Tris-HCl [Tris[hydroxymethyl]aminomethane 
hydrochloride]; pH 8.0). The resuspended cells were added to a lysis solution, containing 0.2 N NaOH 
(Sigma Chemical Co., St. Louis, MO) and 1.0% SDS (wt/vol), and incubated on ice for 10 minutes. 
An appropriate volume of potassium acetate solution (5 M KOAc, pH 4.8) was mixed into the cell 
lysate and centrifuged. The supernatant, containing the plasmid DNA, was extracted with 
phenol/chloroform/isoamyl alcohol and precipitated in 100% isopropanol at-20°C for 30 minutes. The 
plasmid DNA was pelleted by centrifugation, rinsed in 1 ml of 70% ethanol to remove excess salt, 
lyophilized, and resuspended in TE buffer. Incubation (37°C for greater than 1 hour) of the plasmid 
DNA in RNase A degraded the RNA contaminant. The plasmid DNA llllderwent a 
phenol/chloroform/isoamyl extraction to remove the RNase A and any residual proteins. A final 
concentration by precipitation in 100% ethanol was performed (242). 
Quantities of plasmid DNA less than 10 µg were isolated by Wizard™ Plus Miniprep DNA 
Purification Systems (Promega Corporation, Madison, WI). The protocol from the manufacturer was 
modified by increasing the initial volume of overnight liquid bacterial cell culture to 25 ml per 
miniprep. The bacterial cells were pelleted by centrifugation and resuspended in Cell Resuspension 
Solution (50 mM Tris, pH 7.5; 10 mM EDTA; 100 µglml RNase A). Cell Lysis Solution (0.2 N 
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NaOH; 1.0% SDS) was added to the resuspended cells, mixed by inversion of the microcentrifuge 
tubes, and incubated at room temperature for 5 minutes. Neutralization Solution (1.32 M KOAc) was 
mixed into the cell lysate and centrifuged. The supernatant, containing the plasmid DNA, was pipetted 
into a 3 ml syringe (Becton Dickenson and Co., Franklin Lakes, NJ) attached to a Wizard™ 
Minicolumn. Wizard™ DNA Purification Resin was added to the lysate and plunged through the 
roinicolumn. The minicolumn was rinsed with Column Wash Solution (80 mM KOAc; 8.3 mM Tris-
HCl, pH 7.5; 40 µM EDTA; 55% ethanol), removed from the syringe and dried by centrifugation. 
Plasmid DNA was eluted off the mini column by the addition of 1E buffer and centrifugation. 
Plasmid DNA was also isolated by utilizing the PERFECTprep® Plasmid Mini (5 Prime~ 3 
Prime, Inc., Boulder, CO) and Eppendorf Perfectprep Plasmid Mini kits (Brinkmann lnstnnnents, Inc., 
Westbury NY). Two to three ml of bacterial culture was used for each prep. The protocol from the 
manufacturer was modified as follows: all microcentrifugation steps at 16,000 x g were increased to 60 
seconds (vs. 30 seconds) for Salmonella strains; the DNA Binding Matrix Suspension (composition 
unknown) was preheated to 37°C before use; the Elution Buffer (70 µ1 of TE buffer, pH 8.0) was 
preheated to 65°C to facilitate the elution of plasmid DNA from the DNA Binding Matrix; and all 
isolated plasmid DNA was incubated at for 65°C for greater than 15 minutes to heat-inactivate any 
residual nucleases. All plasmid DNA was frozen at -20°C for short-term storage and -78°C for long-
term storage. 
Purification and concentration of DNA. DNA was purified, when necessary, by extraction 
with phenol/chloroform/isoamyl alcohol (242). Phase Lock Gel™ (5 Prime~ 3 Prime, Inc., Boulder, 
CO) microcentrifuge tubes were used during the extraction process according to the manufacturer's 
protocol: an equal volume of DNA sample (genomic or plasmid) and phenol/chloroform/isoamyl 
alcohol were added to a Phase Lock Gel™ microcentrifuge tube, mix~ and centrifuged (14,000 x g) 
for two minutes. A thick density barrier was formed between the upper aqueous phase, containing the 
DNA, and the protein-laden interface and the lower organic phase. The upper aqueous phase was then 
simply poured off into sterile microcentrifuge tubes. A second extraction of the trapped organic phase 
with TE buffer and phenol/chloroform/isoamyl alcohol removed any remaining DNA. The DNA 
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samples were pooled, concentrated by ethanol precipitation, lyophilized, and resuspended in an 
appropriate volume of TE buffer. 
DNA was also pmified and concentrated directly by ethanol precipitation (242). GenElute™ 
LPA, a linear polyacrylamide DNA carrier, ( Supelco, Bellefonte PA) was used in most ethanol 
precipitations of plasmid DNA and amplicons. The protocol from the manufactlll'er was modified by 
increasing the sodium acetate (Sigma Chemical Co., St. Louis, MO) concentration to 0.3 M to facilitate 
a more complete precipitation of the DNA in 100% ethanol (Quantum Chemical CO, Tuscola, IL). 
Precipitated DNA was pelleted by centrifugation (12,000 x g), lyophilized or air-dried at 50°C, and 
resuspended in TE buffer or Molecular Biology Grade water (5 Prime~ 3 Prime, Inc., Boulder, CO). 
All pmified and concentrated DNA was frozen at -20°C for short-term storage and plasmid DNA was 
frozen at -78°C for long-term storage. 
Purification and concentration of DNA from agarose gels. DNA, including amplicons, 
was also pmified and recovered from agarose gels. Bands of electrophoresed genomic or plasmid 
DNA were cut from agarose gels and added to GenElute™ Minus EtBr Spin Columns (Supelco, 
Bellefonte, PA) pre-washed in 1E Buffer. The columns were inserted onto microcentrifuge tubes and 
centrifuged (12,000 x g) for 10 minutes. The columns retained the agarose and ethidium bromide 
while the DNA was eluted by the TE buffer. The DNA was then concentrated, when necessary, by 
ethanol precipitation. 
A second method was also employed for the recovery of DNA from low melt agarose gels. 
After electrophoresis, the band containing the DNA was cut from of the gel and placed in a 0.5 ml 
sterile microcentrifuge tube (Fisher Scientific, Fair Lawn, NJ). The microcentrifuge tube was heated 
to 55°C in a heating block (FisherBrand Dry Bath Incubator; Fisher Scientific, Fair Lawn, NJ). After 
the agarose melted, an equal volume of 10 % (vol/vol) glycerol (Sigma Chemical Co., St. Louis, MO) 
was added. The aqueous solution containing the DNA now remained liquid at room temperatlll'e and 
was utilized directly in restriction endonuclease digests and ligase reactions (244, 245). The plll'ified 
and/or concentrated DNA isolated from agarose gels was frozen at -20°C for storage. 
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Polymerase chain reactions. The polymerase chain reaction (PCR) was utilized for the 
. amplification of specific DNA (246). A GeneAmp PCR System 9600 Thermocycler (Applied 
Biosystems, Foster City, CA) was employed for the 25µ1, 50µ1, or 100µ1 reactions. Primers were 
designed (Table 2) and ordered from GibcoBRL ® (Life Technologies, Inc., Rockville, MD), Life 
Technologies™ (lnvitrogen Corporation, Rockville, MD), and Integrated DNA Technologies 
(Coralville, IA) (247). Three different DNA polymerases were utilized: DyNAzyme™ II, 
DyNAzyme™ EXT (Finnzymes, MJ Research, Inc., Incline Village, NV), and Expand® High Fidelity 
PCR System (Roche Diagnostics Corp., Indianapolis, IN) polymerases (248). Each PCR reaction 
contained 0.016-0.08 U/µl polymerase, 1.5 mMMgC12 in supplied PCR buffer, 0.4-1.6 mM of each 
deoxynucleoside triphosphate, 0.4µM of each primer, nanogram quantities of template DNA, and 
nuclease-free molecular biology grade water (248). PCRreactions were optimized with up to 3.0 mM 
MgCii and/or 2.5 % (vol/vol) dimethyl sulfoxide (DMSO) supplied in the PCR kits (249). Each PCR 
reaction began with an initial template DNA denaturation for 5-7 minutes at 94 °C and ended with a 
final primer extension for 7 minutes at 72°C to ensure that all amplicons were fully extended (250). 
The temperatures and times of the DNA denaturation, primer annealing, and primer extension steps 
(30-35 cycles) varied for each specific PCRreaction (251). 
Quantification of DNA Concentrations of DNA were estimated by ethidium bromide dot 
quantitation (252). Sample DNA, in a series of dilutions in TE Buffer and ethidium bromide (1.0 
µg/ml final concentration), was spotted ohto Parafilm® M (American Can Company, Greenwich, CT) 
and viewed on a ultra-violet transilluminator. A series of standards, lamlxla DNA cut with Hind III 
(Gibco BRL, Gaithersburg, MD), was spotted above the sample DNA Comparison of the 
fluorescence of the sample to these standards provided an estimate of the DNA concentration in the 
sample (252). 
The concentration of DNA was also estimated by comparing the intensity of sample DNA, 
after agarose gel electrophoresis, to a standardized lkb DNA step ladder (Promega Corporation, 
Madison, WI). 
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Endonuclease digests. Restriction endonucleases were purchased from GibcoBRL ® 
(Gaithersburg, MD), New England Bio Labs (Beverly, MA), Promega Corporation (Madison, WI), and 
TaKaRa Biomedicals (Fisher Scientific, Fair Lawn, NJ). The manufacturer's protocols for restriction 
endonuclease digestions were modified for volumes of20-100µ1 using nuclease-free, deionized, 
distilled water (Sigma Chemical Co., St. Louis, MO) (244). Bovine serum albumin (O.ol % [wt/vol]; 
supplied with enzyme) was added to each endonuclease digestion. DNA was digested from one hour 
to overnight with an excess of enzyme (>5U/µg DNA). 
Calf intestinal alkaline phosphatase. Calf intestinal alkaline phosphatase (CIAP) (Promega 
Corporation, Madison, WI) was employed for the hydrolysis of 5'-phosphate groups vector DNA, 
following incubation with a restriction enzyme (253). Three successive CIAP reactions, following the 
manufacturer's protocol, were performed on all vectors digested with a single restriction endonuclease 
prior to ligation to an insert. 
Ligase reactions. T 4 DNA ligase (Promega Corporation, Madison, WI) reactions were 
performed according to the manufacturer's protocol for greater than 12 hours at 16°C. The molar ratios 
ofvector:insert DNA routinely used were 1:1, 1:3, 1:5, 3:1, and 5:1 (245). 
Transformations. E. coli and S. typhimurium competent recipient cells were prepared for all 
transformations according to a modified protocol from Current Protocols in Molecular Biology (254). 
An overnight culture of bacterial cells was grown in Ll.ll"ia broth containing the appropriate antibiotics; 
the fresh overnight culture was diluted (1: 100) into Luria broth lacking the antibiotic and grown to an 
optical density (absorbance @600 nm) of0.5 to 1.0. The cells were chilled on ice and pelleted by 
centrifugation ( 4000 x g) in a Sorvall® Super Speed RC2-B centrifuge (Ivan Sorvall, Inc., Norwalk, 
en for 15 minutes in a cold Sorvall® SS-34 rotor (Dupont Instruments, Norwalk, CT). The 
supernatant was poured off, and the cells were resuspended in the same volume of cold, sterile, 
distilled, deionized water ( ddiH20). The bacterial cells were pelleted by centrifugation, washed again 
in sterile ddiH20, and washed once in 20 ml of 10% (vol/vol) glycerol (Sigma Chemical Co., St. Louis, 
MO). The washed cells were resuspended in 100/o glycerol to a final concentration of approximately 
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1010 cells/ml. These competent recipient cells were used immediately and/or frozen at -78°C for up to 
6 months (254 ). 
Electroporation with high voltage was utilized to introduce DNA into the competent recipient 
cells (254). Each transformation contained 40 µl of chilled competent recipient cells and 1-2 µl of 
ligase reactio~ intact plasmid DNA, or concentrated PCR-amplified DNA fragments. These were 
electroporated in 0.2 cm electrode gap cuvettes (Bio-Rad Laboratories, Hercules, CA) using a Bio-Rad 
Pulse Controller and Bio-Rad Gene Pulser (Bio-Rad Laboratories, Hercules, CA) at 2.5 kV, 25µF, and 
2000. Time constants ranged between 4.0 ms to 4.8 ms. The electroporated cells were then 
incubated, shaking, for 1 hour at 37°C in Luria broth.. After incubation, 100-300 µl aliquots of the 
transformation mixture were spread plated onto Luria agar plates containing the appropriate antibiotic 
(254). 
Determination of growth rate. SR-11 strains were adapted to M9 minimal media separately 
supplemented with various carbon sources with the appropriate antibiotic(s). The cultures were back-
diluted into fresh homologous media to an optical density (absorbance @ 500 nm (OD500)) of 
approximately 0.1 utilizing a Ultraspec 2000® lNNisible Spectrophotometer (Pharmacia Biotech, 
Cambridge, England) using FisherBrand® disposable semi-PS cuvettes (Fisher Scientific, Fair Lawn, 
NJ) (255). The cultures were grown to an OD500 > 1.0 at 37°C with aeration. Data points were 
recorded every 45-60 minutes throughout the experiment, then graphed with Slide Write Plus for 
Wmdows© (version 4.0; Advanced Graphics Software, Inc., Carlesbad, CA). The rate of growth 
(generation time) was calculated from data points in the log {exponential) phase using the formula: 
Generation Time (minutes)= 
Where ti and t2 are the first and second time points in minutes and OD1 and OD2 are their respective 
ODsoo readings (23 7). 
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p-galactosidase assays for era promoter activity. SR-11 strains, containing the era 
promoter-lacZ transcriptional fusion, were adapted to M9 minimal media separately supplemented 
with various carbon sources with the appropriate antibiotic(s). The cultures were back-diluted to an 
ODsoo of~ 0.1 into fresh homologous media containing 150 µglml of ampicillin. The cultures were 
grown at 37°C with aeration to an ODsoo of~ 1.0, then 1 ml samples were removed in triplicate for 
each culture. 
p-galactosidase assays were performed by modified protocols by Miller (232) and Ausubel 
(233). Tue OD600 of the 1 ml samples was measured then centrifuged@l4,000 x gin microcentrifuge 
for 5-10 minutes. The supernatant was removed and the pellet was resuspended in 1 ml ofZ buffer 
(pH 7.0; 1.61% [wt/vol] Na2HP04 • 7H20 (Sigma Chemical Co., St. Louis, MO), 0.55% [wt/vol] 
NaH2P04 • H20 (Sigma Chemical Co., St. Louis, MO), 0.075% [wt/vol] KCl (Sigma Chemical Co., St. 
Louis, MO), 0.0245% [wt/vol] MgS04 • 7H20 (Sigma Chemical Co., St. Louis, MO), and 0.27% 
[vol/vol] J3-mercaptoethanol (Sigma Chemical Co., St. Louis, MO)). One drop of toluene (Sigma 
Chemical Co., St. Louis, MO) was added to each sample, vortexed, and incubated at 37°C for 30 
minutes in a heating block with the caps of the microcentrifuge tubes open to allow the toluene to 
evaporate. One hlllldred microliters of 5 mM ONPG ( orthonitrophenyl-p-o-galactopyranoside; 5 mM 
in Z buffer; Sigma Chemical Co., St. Louis, MO) was added to each sample and incubated at 37°C for 
an additional for 45-64 minutes. Five hlllldred microliters of 1. M Na2C03 (Sigma Chemical Co., St. 
Louis, MO) was added to each sample to stop the reaction and the elapsed time was recorded. The 
samples were centrifuge for 5 minutes@ 14,000 x g and the OD420 and OD550 ofthe supernatant was 
measured. The p-galactosidase activity was calculated using the formula: 
1000 [(OD420) - l.75(0Dsso)] 
Units of (3-galactosidase activity = 
Where t =the time, in minutes, incubated at 37°C and v =·the volume, in milliliters, of culture used in 
the assay. 
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Virulence assays (33, 210). Female BALB/c mice (Charles River Laboratories, Wilmington, 
MA) weighing 13-15 g were housed, at no more than 4 per sterile cage, with pine shavings as bedding. 
Tue mice were fed Prolab RMH2000 pellets (PMI Nutrition International, Inc., Brentwood, MO) and 
sterile deionized, distilled water. The cages were placed in an HEPA-filtered isolation tmit (Britz-
Heidbrink, Inc., Wheatlands, WY) to prevent contamination. Cages, food, water, and bedding were 
changed every other day throughout the entire experiment. All experiments were performed in 
accordance with institutional guidelines for animal care (IACUC Approval Number: A98-03-030). 
All S. typhimurium SR-11 strains utilized in the virulence assays were grown in Luria broth, 
with the appropriate antibiotic( s ), at 3 7°C, with aeration, for 18-19 hours. One ml of each strain was 
centrifuged (10,500 x g) for 5 minutes (certain strains required a second centrifugation to completely 
pellet the cells) in a microcentrifuge and the supernatant was carefully removed. The pelleted cells 
were washed twice in 1 ml of phosphate buffered saline with gelatin (pH 7.2; 0.85% [wt/vol] NaCl, 
0.03% [wt/vol] KH2P04, 0.06% [wt/vol] Na2P04, and 0.1 % [wt/vol] gelatin (Sigma Chemical Co., St. 
Louis, MO)). The washed cells were finally resuspended in 0.5 ml of phosphate buffered saline with 
gelatin and kept on ice. 
The 30 day-old female BALB/c mice were moved to beddingless cages and food and water 
was withheld for 4 hours. At that time, 50 µl of 10% (wt/vol) sodium bicarbonate was administered to 
each mouse after placing the tip of a micropipet just behind the incisors. Approximately 30 minutes 
later, 20 µl of the above strains (ranging.between 7.2 x 107 and 4.3 x 108 bacteria) were separately 
administered perorally to mice in quadruplicate (sham infected mice were fed only the sodium 
bicarbonate). Food, water, and bedding was returned after peroral inoculation. The inocula were 
calculated by serial dilutions of the bacterial cultures into 5 ml saline (0.85% [wt/vol] NaCl) dilution 
tubes, followed by 100 µl spread plates onto MacConkey agar plates containing the appropriate 
antibiotic(s). 
The SR-11 infected mice were observed at least three times daily for signs of illness such as 
ru:ffied fur, eye infections, lethargy, labored breathing, and death. Within 12 hours from the time of 
death, the livers and spleens were removed , weighed, and homogenized (Pyrex #7725 homogenizer; 
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Fisher Scientific, Fair Lawn, NJ) in 1 ml of Luria broth. The homogenates were serial diluted into 
5 ml saline dilution tubes and spread plated onto MacConkey agar containing the appropriate 
antibiotic(s). The cfU/organ were recorded. Surviving SR-11 infected BALB/c mice were sacrificed 
by carbon dioxide asphyxiation 9-21 days post peroral inoculation. The cfU/liver and cfU/spleen were 
also counted and recorded as above. 
The S. typhimurium SR-11 cradl craz integrant control strain. A control strain, S. 
typhimurium SR-11 cradl craz integrant, containing a era promoter-lacZ transcriptional fusion, was 
obtained from Mary P. Leatham (256). The strain was constructed by conjugative-dependent allele 
replacement utilizing the suicide vector pML55cradl-craz (Table 1, Figure 5) (256, 257) The control 
strain carries a partial upstream ilvl gene, an upstream llvH gene, the upstream intergenic sequence, 
and the era promoter ligated to the promoterless lacZ gene from the plasmid pCB267 (Figure 5) (256, 
258). Approximately 94 7 bp of DNA upstream of the era promoter were engineered into this construct 
to retain any possible regulatory sequences (256, 259). The 3' end of the lacZ reporter gene is ligated 
to approximately 200 bp of the remaining truncated era gene, followed by approximately 534 bp of 
downstream DNA (a partialyabB gene) (Figure 5) (256). Since SR-11 cradl craz integrant is a partial 
diploid, containing both a wild-type era gene and a era promoter ligated to a reporter gene (Figure 5), 
it is able to utilize fatty acids and gluconeogenic substrates as sole carbon sources (231, 256, 257). 
The SR-11 cradl craz integrant strain was used as a control to ~easure the era promoter activity (J3-
galactosidase assays) during growth on glycolytic and gluconeogenic substrates. 
Construction of S. typhimurium SR-11 mutants by allelic exchange. An S. typhimurium 
SR-11 fbp- mutant was constructed by conjugative-dependent allele replacement (239, 257). Since the 
genome was not fully sequenced and the homology between S. typhimurium and E coli was 
approximately 85% identical at the nucleotide level, the E coli fructose-1,6-bisphosphatase (jbp) DNA 
sequence was obtained using PubMed and Entrez Protein (66, 260-262). The S. typhimurium DNA 
sequence of the jbp gene was then pieced together from contig518 and contig 1460 of the S. 
typhimurium LT2 llllfinished fragments of the complete genome using BLASTn (263, 264). ORF 
Finder was utilized to determine the translational start and stop codons of the jbp gene (265). The 
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DNA sequence of the fop, as well as the gene directly upstream (yi.fG) and directly downstream (yijF), 
were processed in Webcutter to find the restriction endonuclease sites (266). Primers for PCR were 
designed to make a permanent deletion in the fop gene in which a chloramphenicol resistance gene 
could be inserted for selection purposes. The primers were also designed for the amplicon to be ligated 
into both the phagemid cloning vector pBluescript II SK ( +) and the suicide vector pLD55 for 
conjugation and allelic exchange (Table 2) (257, 267, 268) 
Using S. typhimurium SR-11 wild-type genomic DNA as a template and the yi,jF/forward and 
yijG/reverse primers (Table 2), a 3089 base pair (bp) fragment was amplified by PCR This amplicon 
contained 1023 bp upstream (a partial yifG gene) and 1072 bp downstream (a partial yi,fF gene) of the 
jbp gene. The amplicon was digested with Bam HI and Not I and ligated into the Bam HI/Not I-double 
digested cloning vector pBluescript II SK ( + ). The ligase reaction was electroporated into E coli 
HB101 competent recipient cells. The resulting plasmid, pJHA:fbp+, was isolated and verified by PCR 
and restriction mapping (Figure 6) (269). 
A deletion of878 bp from thefop gene was made by amplifying around pJHA:fbp+ (Figure 7) 
by PCR using the fop-DEL/forward and fop-DEL/reverse deletion primers (Table 2). The amplicon 
was digested with Bam HI, ligated to itself, and electroporated into E coli XL I-Blue MRF' competent 
cells. The result of the transformation yielded the plasmid p!1fop (Figure 8). The chloramphenicol 
resistance cassette from pJHA 7 (Table 1) was digested with Barn HI, ligated into Bam HI-digested 
p4fbp, and electroporated into E coli XLl-Blue MRF' to produce the plasmid p/1fopCam (Figure 9). 
The plasmids pJHA:fbp+, p!1fop, and p/1fo[£,am were verified by PCR and restriction mapping. These 
plasmids were also sequenced (270-272) by Intervet International B.V. (Boxmeer, Netherlands) to 
confirm the fop gene was cloned and deleted. 
The plasmid p4fbpCarn (Figure 9) was digested with Bam HI and Not I and ligated into the 
Bam HI/Not I-double digested suicide vector pLD55 (Table 1). This ligase reaction was electroporated 
into the host strain E. coli S 17-1 A. pir and the suicide vector p55!1fopCarn was subsequently isolated 
and verified by PCR and restriction mapping (Figure 10) (257, 273). 
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The temperature-sensitive donor strain£. coli Sl 7-1 'Apir (p55~jbpCam) was grown 
overnight at 30°C in LB containing ampicillin and chloramphenicol to retain the plasmid (273). An 
overnight culture of the recipient strain, S. typhimurium SR-11 wild-type, was grown in LB containing 
nalidixic acid. A conjugation was performed by mixing 200 µ1 each of the donor and recipient strains 
in 5 ml of 10 mM MgS04 (273, 274). The mixture was suctioned through a Millipore® Vacmnn 
Filtration System (Millipore Corporation, Bedford, MA) containing a sterile 0.45 µm cellulose nitrate 
filter (Micro Filtration Systems, Dublin, CA). The membrane was placed, bacteria side up, on a pre-
wanned LB agar plate and incubated for 5 hours at 37°C. After incubation, the membrane filter 
removed and vortexed in 5 ml of sterile 0.85% (wt/vol) saline. Aliquots of 50, 100, 200, and 300 µl of 
the cells were spread plated onto LB agar plates containing chloramphenicol and nalidixic acid to 
select for partial diploid integrants (275). PCR, using colonies as template DNA, was utilized to 
screen for the correct exconjugant which successfully achieved homologous recombination with 
integration of the suicide vector p55~.fbpCam into its genome (257). The exconjugant was designated 
S. typhimurium SR-11~jb[£am1-3 integrant (Figure 10). 
Since S. typhimurium SR-11 ~jb[£am 1-3 integrant is a partial diploid, containing both a 
wild-type and deleted.fbp gene (Figure 11), a second recombinational event was required to select for a 
jbp- segregant (Figure 12). This was accomplished by positive selection for the loss of tetracycline 
resistance (239). An overnight culture ofSR-11~jbpCam1-3 mtegrant was grown in LB 
supplemented with chloramphenicol and subcultured, at an approximate concentration of 106 colony 
forming llllits ( cfu)/ml, into fusaric acid selection medhnn supplemented with chloramphenicol. The 
culture was incubated at 37°C, with aeration, for 48 hours then serial diluted to approximately 103 
cfu/ml (276). One hundred µ1 of the 103, 104, and 105 dilutions were spread plated onto fusaric acid 
agar plates containing chloramphenicol. Chloramphenicol-resistant, nalidixic acid-resistant, 
tetracycline-sensitive segregant colonies were screened for the absence of growth on M9 minimal agar 
media supplemented separately with various gluconeogenic substrates. One such colony was chosen 
and designated S. typhimurium SR-11 4fbpCam AX-3 segregant (Figure 12). The deletion ofthejbp 
gene in the genome of this strain was confirmed by PCR 
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Mutations in the maeB gene (encoding the gluconeogenic NADP-dependent malic enzyme), 
sfcA gene (encoding the gluconeogenic NAD-dependent malic enzyme), and the pta gene (encoding 
the enzyme phosphotransacetylase) were constructed in S. typhimurium SR-11 wild-type (277-280) 
(Figure 1 ). These separate mutations were constructed by allelic exchange with a slightly modified 
one-step inactivation of chromosomal genes using PCR products method as described by Datsenko and 
wanner (281). The sequences, open reading frames, translational start and stop codons, the upstream 
and downstream genes, and the restriction endonuclease sites were determined for each gene as 
described above for thejbp gene (282-297, 298-301). 
Deletion primers for PCR (Table 2) were designed with 45 nucleotides of homology within 
the wild-type maeB, sfrA and pta genes. The primers were also engineered with 20 nucleotides of 
homology to the kanamycin resistance gene in pKD4 (Table 1 ). Using pKD4 as template DNA and the 
deletion primers, five 100 µl PCR r~ctions for each gene to be deleted were performed. The 
amplicons now contained a kanamycin resistant gene flanked by sequences homologous to the wild-
type maeB, sfrA or pta genes (Figure 13). The PCRreactions were pooled (500 µI/gene to be deleted), 
purified, and concentrated to approximately 10 µI. 
S. typhimurium SR-11 (pKD46) was grown in SOB media, containing 150 µglml of 
ampicillin and 20 mM L-arabinose (the gene encoding 'A Red recombinase, which greatly enhances the 
rate of homologous recombination, is located the plasmid pKD46 and is controlled by an arabinose-
inducible promoter), at 30°C to an OD600 'of~ 0.6 and then made electrocompetent (254, 255). Two 
microliters of the concentrated linear DNA amplicons from above were electroporated into 40 µl of 
fresh electrocompetent cells and incubated at 3 7°C in 1 ml of SOC media for 1 hour. Five 100 µl 
aliquots were spread plated onto LB plates, containing either 50, 60, or 70 µglml ofkanamycin, and 
incubated at 37°C to cure any transfonnants of the temperature-sensitive plasmid The remainder of 
the electroporated culture was incubated overnight at room temperature and then spread plated as 
above. Transfonnants which successfitlly underwent homologous recombination (Figure 13) were 
kanamycin-resistant and ampicillin-sensitive. Deletions in the maeB, sfrA or pta genes were 
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confirmed by PCR utilizing flanking confirmation primers (Table 2). These strains were designated S. 
typhimurium SR-11 maeE, SR-11 sfcA-, and SR-11 ptd respectively (Table 1). 
The strains S. typhimurium SR-11 cradl craz integrant (256), SR-11 maeE cradl craz 
integrant, SR-11 sfoA- cradl craz integrant, and SR-11 ptd cradl craz integrant (Table 1) were 
constructed to assay for era promoter activity (231 ). The strains were constructed by conjugative-
dependent allele replacement which utilized the donor strain E. coli S 17-1 J..pir (pML55cradl-craz) 
(Table 1). The suicide vector pML55cradl-craz contained a era promoter-/acZtranscriptional fusion, 
plus DNA sequences flanking the era gene, ligated into the suicide vector pLD55 (Table 1) (257). 
Exconjugants which successfully achieved homologous recombination with integration of the suicide 
vector pML55cradl-craz into its genome were selected on LB plates containing ampicillin and 
kanamycin (257). The integrants were confirmed on LB plates containing tetracycline, XLD plates, 
and LB plates containing approximately 70 µglml ofX-Gal (5-bromo-4-chloro-3-indolyl-J3-n-
galactopyranoside; Sigma Chemical Co., St. Louis, MO) (302). The integrants are partial diploids, 
containing both a wild-type era gene and a era promoter-lacZ transcriptional fusion; these strains were 
therefore also confirmed for growth on M9 minimal agar plates separately supplemented with various 
carbon sources. The kanamycin resistance cassette, as well as the era promoter-lacZ transcriptional 
fusion (using era-COMP/forward and /acZ/reverse primers), were confirmed by PCR 
Complementation of the era- andjbp- genes. The S. typhimurium SR-11 Fad- strain was 
complemented (211) with the plasmid plliA8 containing the wild-type era gene (Table 1 ). The 
plasmid pIBA8 was constructed with PCR by amplifying the era gene from SR-11 wild-type template 
genomic DNA and primers (era-COMP/forward and era-COMP/reverse primers) 128 bp upstream of 
the translational start codon and 293 bp downstream of the translational stop codon (Table 2). The 1.4 
kbp amplicon was digested with Pst I and ligated into the Pst I site of the cloning vector pBR322 
yielding the plasmid plliA8 (303). The plasmid was electroporated into the cloning strain, E. coli · 
HBlOl, and isolated (Table 1). The plasmid was then electroporated into S. typhimurium MS1868, a 
restrictionless strain which modified the plasmid DNA (Table 1) (304). After isolating the modified 
plasmid DNA, it was electroporated into the SR-11 Fad- strain (Table 1 ). 
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The S. typhimurium SR-11 4fbpCam AX-3 segregant strain was complemented with a 
plasmid containing the wild-type fbp gene (211 ). Utilizing SR-11 wild-type genomic DNA as a 
template and the yijF/forward and yifG/reverse primers (Table 2), a 3089 bp fragment was amplified 
by pCR This amplicon contained 1023 bp upstream (a partial yifG gene) and 1072 bp downstream (a 
partial yifF gene) of the jbp gene. The amplicon was digested with Bam 1-Il and Not I and ligated into 
the Bam lil/Not I-double digested cloning vector pBluescript II SK(+). The resulting plasmid, pJHA-
jbp+ (Figure 6), was electroporated into S. typhimurium MS1868, isolated, and then electroporated into 
the SR-11 4fbpCam AX-3 segregant strain. 
Statistics using the Student t distribution. To determine ifthe differences observed in p-
galactosidase activities were significant, the student t distribution was calculated using a P value of 
0.05. Significance or insignificance was reported with a 95% confidence limit (305). 
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Construction, confirmation, and characterization of the S. typhimurium SR-11 jbp-
mutant. A mutation in thejbp gene, which encodes the gluconeogenic enzyme fructose-1,6-
bisphosphatase was constructed in S. typhimurium SR-11 (Figure 1 ). A deletion of 878 bp from the 
wild-type jbp gene was made and replaced with a chloramphenicol resistance cassette. The resulting S. 
typhimurium SR-11 4fbpCam AX-3 segregantjbp-mutant strain was confirmed byPCR(Figure 14). 
The SR-11 jbp- mutant strain, like the SR-11 Fad- vaccine strain, was unable to utilize 
gluconeogenic substrates as sole carbon sources when streaked onto M9 minimal agar plates (Table 3). 
With the expected exception of the SR-1 lfbp- mutant's inability to metabolize glycerol as a sole 
carbon source, the phenotypes observed were identical to the SR-11 Fad- vaccine strain. Furthermore, 
complementation with a wild-type.fbp gene on the plasmid plliA:fbp+, restored the ability of the SR-
11 jbp- mutant to utilize gluconeogenic substrates as sole carbon sources on M9 minimal agar plates. 
Virulence of the S. typhimurium SR-11 AjbpCam AX-3 segregant in BALB/c mice. The 
SR-11 jbp- mutant strain was administered perorally (inoculation of approximately 2.4 x 108 cfu) to 30 
day-old female BALB/c mice and was found to be virulent (Table 4). The cfu recovered from the 
livers and spleens ofthe mice fed the SR-1 lfbp- mutant strain were similar to the numbers ofbacteria 
recovered from the mice fed the SR-11 wild-type control strain (Table 4). A mortality rate of 100% 
was observed in the SR-11 jbp- mutant at the same inoculum that is 100% avirulent in the SR-11 Fad-
vaccine strain. 
P-galactosidase assays, for era promoter activity, in the SR-11 cradl craz integrant. The 
era promoter activity was highest in SR-11 cradl craz integrant when grown on gluconeogenic 
substrates (Table 5). The highest era promoter activity was observed on succinate (3.3 units), followed 
by malate, pyruvate, citrate, oleate, acetate, and phospho{enol)pyruvate (1.7 units). The J3-
galactosidase assays in SR-11 cradl craz integrant were lower when grown on glycolytic substrates 
versus gluconeogenic substrates (Table 5). For glycolytic substrates, the highest era promoter activity 
was observed on glucose (1.3 units), followed by gluconate (1.0 units), and lowest on fructose (0.9 
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units). As expected, the ~-galactosidase assays revealed no activity in the SR-11 wild-type control 
grown on glucose (0.0 units). 
The ratio of the ~-galactosidase units for each substrate assayed relative to the ~-galactosidase 
units for fructose, the lowest era promoter activity observed (0.9 units), was calculated. The highest 
ratio, at 3.6, was for the SR-11 cradl craz integrant when grown on succinate (Table 6, Figure 15). 
This translates to 3.6 times more era promoter activity observed when grown on succinate versus 
fructose. The average increase in era promoter activity, for all the gluconeogenic substrates tested, 
was 2.5-fold above the era promoter activity for growth on fructose. 
The generation times of SR-11 cradl craz integrant when grown on gluconeogenic substrates 
were longer than when grown on glycolytic substrates (Table 5). The generation times on 
gluconeogenic substrates were greater 100 minutes, whereas on glycolytic substrates, the generation 
times were less than 91 minutes. The fastest growth rate for the SR-11 cradl craz integrant was 
recorded in M9 minimal broth supplemented with fructose (73 minutes). 
Construction, confirmation, and characterization of the S. typhimurium SR-11 maeK 
and SR-11 sfcA- mutants. Mutations in the maeB gene (encoding the gluconeogenic NADP-
dependent malic enzyme) and the sfeA gene (encoding the gluconeogenic NAO-dependent malic 
enzyme) were constructed in S. typhimurium SR-11 (Figure 1 ). A deletion of 2191 bp from the wild-
type maeB gene and a separate deletion of 1612 bp from the wild-type sfeA gene were made; both 
deletions were replaced with a kanamycin resistance cassette. The resulting S. typhimurium SR-11 
mae/J" and S typhimurium SR-11 sfi::A- mutant strains were confirmed by PCR (Figure 16, 17, 18). 
The S typhimurium SR-11 maeE and sfi::A- mutants grew as well as the SR-11 wild-type on 
M9 minimal agar plates supplemented with glucose or fructose, but grew more slowly, versus the wild-
type, on M9 minimal agar plates supplemented with malate or succinate. Noticeably longer generation 
times for the SR-11 maeff and sfi::A- mutants, versus the SR-11 wild-type, were observed in both 
mutants when grown on malate or succinate in M9 minimal broth (Table 7). The differences in growth 
rates of all three strains were minor when utilizing glycolytic substrates as sole carbon sources (Table 
7). 
54 
f3-galactosidase assays, for era promoter activity, in the S. typhimurium SR-11 maeH 
cradl craz integrant and the SR-11 sf cA- cradl craz integrant The era promoter activity in the SR-
l l maeff mutant, measured by f3-galactosidase assays, was slightly down-regulated (l.1- to 1.4-fold) 
on the two gluconeogenic substrates and one glycolytic substrate, versus the SR-11 cradl craz integrant 
control strain (Table 8). The greatest down-regulation was observed for growth on succinate (1.4-
fold), followed by malate (1.1-fold), and glucose (1.1-fold). The era promoter activity in the SR-11 
maeff mutant was essentially the same as the control strain when grown on fructose (Table 8). 
The era promoter activity was significantly up-regulated (P = 0.05) in the SR-11 sfcA- mutant 
on both gluconeogenic and glycolytic substrates, versus the SR-11 cradl craz integrant control strain 
(Table 8). The greatest up-regulation was observed for growth on malate (2.8-fold), followed by 
glucose (2.7-fold), fructose (2.5-fold), and succinate (2.3-fold). 
Virulence of the S. typhimurium SR-11 maeH and SR-11 sf cA- mutants in BALB/c mice. 
The S. typhimurium SR-11 maelf and SR-11 sfcA- mutant strains were virulent when administered 
perorally (inoculation of approximately 1.3 x 108 cfu) to 33 day-old female BALB/c mice. A mortality 
rate of 100% was observed in BALB/c mice fed either the SR-11 maeB- mutant strain or the SR-11 
sfeA-mutant strain (Table 9). The day of expiration post-peroral inoculation for the BALB/c mice fed 
the SR-11 maeB- and the SR-11 sfcA- strains was similar to age-matched BALB/c mice fed the SR-11 
wild-type control (Table 9). The cfu recovered from the livers and spleens of the mice fed the SR-11 
maeB- mutant strain (4.8 x 107 cfu and 3.9 x 107 cfu respectively) were approximately 1/2 ofa log 
below the numbers of bacteria recovered from the mice fed the SR-11 wild-type control strain (Table 
9). The cfu from the livers and spleens of the mice fed the SR-11 sfeA- mutant strain (1.5 x 107 cfu and 
7.9 x 107 cfu respectively) were approximately 1 log below the cfu recovered from the SR-11 wild-
type control strain (Table 9). 
The S. typhimurium SR-11 sfeA- mutant strain was also fed (inoculation of approximately 2.1 
x 108 cfu) to 50 day-old female BALB/c mice. Again, the SR-11 sfeA- mutant strain was found to be 
virulent with a 100% mortality rate (Table 10). The day of expiration post-peroral inoculation for the 
BALB/c mice fed the sfcA- mutant strain was similar to the age-matched BALB/c mice fed the SR-11 
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wild-type control (Table 10). The cfu recovered from the livers and spleens ofthe mice fed the SR-11 
sfcA- mutant strain were slightly elevated versus the mnnbers of bacteria recovered from the mice fed 
the SR-11 wild-type control strain (Table 10). 
Construction, confirmation, and characterization of the S. typhimurium SR-11 pta-
mutant. To further examine the regulation of the global regulatory era gene, a mutation in the pta 
gene, which encodes the enzyme phosphotransacetylase was constructed in S. typhimurium SR-11 
(Figure 1 ). A deletion of 1911 bp from the wild-type pta gene was made and replaced with a 
kanamycin resistance cassette. The resulting S. typhimurium SR-11 ptd mutant strain was confirmed 
by PCR (Figure 19). 
The SR-11 ptd mutant strain was also unable to utilize acetate as a sole carbon sol.ll'ce in both 
M9 minimal agar plates and M9 minimal broth supplemented with potasshnn acetate. The generation 
times ofthe SR-11 pta- cradl craz integrant were 19 minutes (22%) longer on glucose and 31 minutes 
(31%) longer on fructose, versus the SR-11 cradl craz integrant control, in M9 minimal broth (Table 
11). The differences in the generation times of the SR-11 ptd cradl craz integrant and the SR-11 cradl 
craz integrant control were minor for growth on succinate and malate (Table 11 ). 
(3-galactosidase assays, for era promoter activity, in the SR-11 pta- cradl craz integrant. 
The era promoter activity was significantly (P = 0.05) up-regulated (3.0- to 3.4-fold) in the SR-11 ptd 
cradl craz integrant using both gluconeogenic and glycolytic substrates, versus the SR-11 cradl craz 
integrant control strain (Table 12). The greatest up-regulation was observed for growth on glucose 
(3.4-fold), followed by succinate (3.1-fold), malate (3.0-fold), and fructose (3.0-fold) (Table 12). 
Virulence of the S. typhimurium SR-11 pta- mutant in BALB/c mice. The S. typhimurium 
SR-11 pta- mutant strain was administered perorally (inoculation of approximately 1.6 x 108 cfu) to 33 
day-old female BALB/c mice and was found to be avirulent (Table 13). However, the mice showed 
signs of disease: ruffled fur, eye infections, and lethargy. Two mice recovered by Day14 of the 
experiment and the remaining two mice were also recovering. The intensity of the disease was not as 
proooWlced as the mice fed the SR-11 wild-type strain. The cfu recovered from the livers and spleens 
of the mice fed the SR-11 pta- mutant strain ( 6.9 x 106 cfu and 6. 7 x 106 cfu respectively), sacrificed on 
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Day
15
, were 1.3 logs less than mnnbers of bacteria recovered from the mice fed the SR-11 wild-type 
control strain (Table 13). 
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m_scussion 
The link between gluconeogenesis in S. typhimu.rium SR-11 and virulence in BALB/c 
mice. Like the SR-11 Fad- vaccine strain, gluconeogenesis is interrupted in the SR-11 jbp- mutant, yet 
the SR-11 jbp- mutant strain proved virulent in BALB/c mice. This indicates that general interruption 
of the gluconeogenic pathway is not the reason for the SR-11 Fad- vaccine strain's avirulence in 
BALB/c mice. The Cra protein may be involved in the regulation of some other cellular function 
related to virulence or µM concentrations of glucose or other glycolytic substrate(s) were available in 
vivo for SR-1 ljbp- mutant strain (growth in vitro requires 80-160 µM glucose). Co-metabolism, 
utilizing both glycolytic and gluconeogenic substrates, may have occurred in the SR-11 jbp- mutant in 
vivo. 
The availability of µM concentrations of glucose or another glycolytic substrate(s) would 
allow the biosynthesis of essential metabolites such as ribose-5-phosphate for ribonucleotides and 
deoxynucleotides, erythrose-4-phosphate for aromatic amino acids, and glucose-6-phosphate and 
pentose-5-phosphate for LPS (69, 76). Without co-metabolism from a separate glycolytic substrate 
such as glucose, these metabolites would not be biosynthesized in an SR-11 jbp- mutant, since 
gluconeogenesis is blocked at :fructose-1,6-bisphosphate and never reaches glucose-6-phosphate and 
the pentose phosphate pathway (Figure 1 ). Furthermore, it appears that in vivo, mM concentrations of 
the era effector :fructose-1,6-bisphosphate did not accumulate and. inactivate the Cra DNA binding 
protein (Figure 1 ). The SR-11 jbp- mutant, in vivo, appears to possess a functioning Cra protein, unlike 
the SR-11 Fad-vaccine strain which is avirulent in BALB/c mice (Table 4) (33, 210). 
A subsequent publication revealed the existence of a second :fructose-1,6-bisphosphatase in E. 
coli encoded by the glpX gene (306). S. typhimurium also contains this redlllldant :fructose-1,6-
bisphosphatase enzyme (307). After this research was completed, an SR-11 jbp- glpX double mutant, 
also tmable to utilize gluconeogenic substrates as sole carbon sources in vitro, was constructed and 
proved to be virulent in BALB/c mice (308). 
The SR-11 Fad-, llllable to utilize gluconeogenic substrates as sole carbon sources in vitro 
(Table 3), was able to invade and was viable in enclosed vacuoles within M cells of the Peyer's patches 
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in BALB/c mice (33). Additionally, when SR-11 Fad- crd is fed to BALB/c mice, lowmnnbers of the 
strain (approximately 103 cfu) were recovered from both the liver and spleen (Table 4). 1bis suggests 
that the SR-11 Fad- and the SR-1 ljbp- mutant both have access in vivo to a glycolytic substrate in 
BALB/c mice. 
Clearly, the SR-11 jbp- mutant's interruption "high" in the gluconeogenic pathway does not 
renders. typhimurium SR-11 avirulent in BALB/c mice (Figure 1, Table 4). Either co-metabolism 
utilizing both gluconeogenic and glycolytic substrates occurs in vivo, or the Cra protein is involved in 
the regulation of some other cellular function related to virulence. Perhaps the TCA cycle must 
generate a sufficient concentration of the precursor metabolite phospho(enol)pyruvate via malate or 
oxaloacetate for virulence (Figure 1 ). PTS carbohydrate phosphorylation is coupled to carbohydrate 
translocation across the cytoplasmic membrane; the energy for these processes being provided by the 
precursor metabolite phospho(enol)pyruvate (91). The general PTS proteins, EI and HPr, transfer 
phosphoryl groups from phospho(enol)pyruvate to the sugar-specific transporters (EIISllfPI) in the PTS 
system (91, 207). A strain of S. typhimurium, with a mutation in the ptsH-encoded EI enzyme of the 
PJ'S system, has been reported as attenuated for virulence in BALB/c mice (207). The PTS system is 
also an integral part of cAMP-CRP regulation ( catabolite repression) and the genes of its regulon (183-
185). The live oral S. typhimurium ~cya (adenylate cyclase) ~crp (cAMP receptor protein) vaccine is 
based on deletions in the cAMP-CRP global regulatory system (197). The above mutant strains, both 
attenuated for virulence in BALB/c mice,-reveal the importance for a fully functional PTS system 
driven by the precursor metabolite phospho( enol)pyruvate; the SR-11 jbp- mutant, although blocked in 
the gluconoegenic pathway at fructose-1,6-bisphosphate, may have generated a sufficient 
concentration of phospho( enol )pyruvate (Figure 1 ). 
A S. typhimurium sfcA- mutant, deficient in the NAD-dependent malic enzyme, was reported 
to be avirulent in BALB/c mice (20, 80). Furthermore, four-carbon gluconeogenic substrates such as 
malate and/or oxaloacetate were noted as clearly important for growth in the murine host (20). Unlike 
the SR-11 fbp- mutant, where gluconeogenesis is interrupted up "high" in the gluconeogenic pathway, 
the reported sfcA- mutant interrupts gluconeogenesis directly off the TCA cycle (Figure 1). The 
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difference in the location of the interruption in the gluconeogenic pathway may account for the 
virulence observed in the SR-11 jbp- mutant. 
The era promoter activity in the SR-11 cradl craz integrant To further investigate the 
link between the era gene, gluconeogenesis, and virulence in BALB/c mice, the era promoter activity 
in the SR-11 cradl craz integrant (containing a era promoter-lacZ transcriptional fusion) was 
determined for growth on various glycolytic and gluconeogenic substrates {104, 232, 233). Overall, 
the era promoter activity was up-regulated (1.6- to 3.1-fold) when grown on gluconeogenic substrates 
versus glycolytic substrates (Table 5). The average increase in era promoter activity, for all the 
gluconeogenic substrates tested, was 2.5-fold above the era promoter activity for growth on fructose 
(Table 6, Figure 15). Except for pyruvate, the era promoter activities were highest for growth on 
substrates within the TCA cycle. These data are consistent with the fimction of the Cra protein: up-
regulation of transcription of genes encoding enzymes involved in gluconeogenesis {specific enzymes 
in the TCA cycle, the glyoxylate shllllt, and the gluconeogenic pathway) and repression of transcription 
of genes encoding glycolytic enzymes {specific enzymes in the Embden-Meyerhof-Parnas and Entner-
Doudoro:ffpathways) (Figure 3) (212, 217-219). Furthermore, gluconeogenesis or one of the 
metabolites in the gluconeogenic pathway appears to up-regulate era promoter activity. 
The era promoter activity of SR-11 cradl craz integrant during growth on malate was up-
regulated by 2.1-fold higher versus growth on glucose (Table 5). S. typhimurium contains two 
redundant malic enzymes: an NAD-dependent malic enzyme (encoded by the sfcA gene) and NADP-
dependent malic enzyme (encoded by the maeB gene) (123, 125, 126). Both enzymes are malate 
oxidoreductases which convert malate, normally present in the TCA cycle, to pyruvate (Figure 1) (125, 
126, 309, 310). Both biochemical reactions, studied more extensively in E. coli, are essentially 
irreversible (81, 309-311). In E.coli, it has been suggested that the ifcA-encoded NAD-dependent 
malic enzyme is involved in gluconeogenesis and that the maeB-encoded NADP-dependent malic 
enzyme supplies the cell with NADPH when growing on C4 carbon sources (312). Another study in E. 
coli suggested that the NADP-dependent malic enzyme is also involved in the supply of acetyl-CoA 
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from malate, which is utilized for the biosynthesis of lipids as well as for the maintenance of TCA 
cycle intennediates (310). 
During growth on gluconeogenic substrates such as malate (succinate, citrate, pyruvate, 
acetate, or oleate) the pyruvate pool is divided between conversion to phospho(enol)pyruvate (up the 
gluconeogenic pathway) and conversion to acetyl-CoA to fuel the TCA cycle; both routes are required 
for the biosynthesis of precursor metabolites for growth (Figure 1 ). Because of the high demand for 
acetyl-CoA to fuel the TCA cycle, it is tmlikely that much of the acetyl-CoA is converted to acetyl 
phosphate (Figure 1 ). 
The era promoter activity in SR-11 cradl craz integrant grown on the glycolytic substrate 
glucose was 2.1-fold lower than when grown on malate (Table 5). In these non-limiting glucose 
growth conditions, an incomplete branched, biosynthetic form of the TCA cycle is utilized (Figure 2) 
(74, 78). The full TCA cycle is not required under these conditions because the bulk of energy is 
derived from glycolysis (74, 78). In this glucose-rich environment, cells produce excess acetyl-CoA 
which drains through acetyl phosphate, to further produce ATP with the associated secretion of acetate 
(Figure 2) (78, 79). As cell density increases, the build-up of acetate also serves to increase the size of 
the acetyl phosphate pool (78). 
The era promoter activity for SR-11 cradl craz integrant cells grown on acetate was 1.4-fold 
higher than glucose-grown cells (Table 5). S. typhimurium contiins two pathways for the utilization of 
acetate: the first pathway is a direct route to acetyl-CoA catalyzed by the acs gene product acetyl-CoA 
synthetase; the second pathway forms the intermediate metabolite, acetyl phosphate, catalyzed by the 
ackA-encoded acetate kinase A enzyme and then acetyl-CoA is formed by the pta-encoded 
phosphotransacetylase enzyme (Figure 1) (279, 280, 313-316). Biochemical studies in E. coli on the 
acs pathway and the pta-ackA pathway, which both lead to acetyl-CoA, may have clarified their 
function (Figure 1) (317-319). In these biochemical studies, the pta and ackA genes were both down-
regulated by approximately 2-fold while the acs gene was induced by greater than 8-fold in a global 
expression profiling experiment of acetate-grown E. coli using glucose grown cultures as a reference 
(317). In another experiment, investigating the global regulation of the main metabolic pathways of E. 
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l . 1-.~,,,,.A on 2-dimensional electrophoresis, similar results were observed: the pta-encoded and aekA-co z~ 
encoded enzymes were down-regulated (1.3-fold and 1.7-fold respectively) for aerobic growth on 
acetate versus the glucose-grown control (318). These combined data for both experiments suggest 
that the acs gene pathway is mainly responsible for acetate uptake, whereas the pta-ackA pathway is 
utilized for acetate excretion (Figure 1) (317-319). Consequently, a limited pool of acetyl phosphate 
would be expected for aerobic growth in acetate. 
Overall, the predicted size of the acetyl phosphate pool, the biochemical pathways utilized, 
and the data from the f3-galactosidase assays, implicate acetyl phosphate in the regulation of the era 
gene; acetyl phosphate appears to function, indirectly or directly, as a repressor of the era gene. 
Furthennore, acetyl phosphate is a logical candidate since it is a known global regulator of chemotaxis, 
the phosphate-specific transport system, and nitrogen regulation (24, 79, 189, 190). Acetyl phosphate 
also has been proposed to play a role in outer membrane proteins involved in osmo-regulation and the 
regulation of enzymes in the TCA cycle and glyoxylate shunt (24, 79, 189, 190). 
The era promoter activity of the S. typhimu.tium SR-11 ma.eH, SR-11 sfcA-, and SR-11 
pta· mutants. AS. typhimurium sfeA· mutant was reported to be avirulent in BALB/c mice and the 
importance of four carbon gluconeogenic substrates such malate and/or oxaloacetate for growth in the 
murine host was implied (20, 80). This warranted further study and also suggested that the sfcA gene 
may be involved in the regulation of the era gene or the Cra protein. To test this hypothesis and the 
above implication that acetyl phosphate appears to function as a repressor of the era gene, deletions in 
the maeB, sfeA, and pta genes were constructed in S. typhimurium SR-11 wild-type. 
The generation times of the SR-11 maeE, and SR-11 sfeA· mutants were essentially the same 
as the SR-11 wild-type for growth in M9 minimal broth supplemented with glucose or fructose (Table 
7). However, considerably longer generation times (versus the SR-11 wild-type) for both the SR-11 
maeB" and SR-11 sfeA- mutants were observed for growth in malate or succinate (Table 7). This 
suggests that both malic enzymes are required for maximum growth rates when utilizing 
gluconeogenic substrates. Conversely, both malic enzymes are not required for maximum growth rates 
when utilizing glycolytic substrates. 
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Of interest, the SR-11 maeE mutant's growth rate was 12 minutes (11%) slower on succinate 
and 41 minutes (22%) slower on malate than the SR-11 sfcA-mutant grown on these gluconeogenic 
substrates (Table 7). These differences in growth rates may be due to the reported functions of the 
malic enzymes: the sfcA-encoded NAD-dependent malic enzyme is involved in gluconeogenesis 
whereas the maeB-encoded NADP-dependent malic enzyme supplies the cell with NADPH when 
growing on C4 carbon sources and is also involved in the supply of acetyl-CoA from malate, which is 
utilized for the biosynthesis of lipids as well as for the maintenance of TCA cycle intermediates (310, 
312). 
Overall, considering the long generation times for growth in gluconeogenic substrates, a 
deletion in the pta gene in the SR-11 pta- cradl craz integrant strain exhibited minor pleiotropic effects 
for growth utilizing gluconeogenic substrates (Table 11 ). Conversely, the growth rate of the SR-11 
ptd cradl craz integrant was 19 minutes (22%) slower on glucose and 31 minutes (31%) slower on 
fructose versus the SR-11 cradl craz integrant control (Table 11 ). Excess acetyl-CoA cannot drain 
through acetyl phosphate, to further produce A 1P with the associated secretion of acetate in the SR-11 
ptd cradl craz integrant (Figure 2). This implies that the pta gene, and the ability to produce acetyl 
phosphate from acetyl-CoA, appear to be required for maximum growth rates when utilizing glycolytic 
substrates (Table 11 ). A similar conclusion was reported for the growth of E. coli in glucose: the 
ability to produce acetyl phosphate influences (depresses) the ~ growth rate (79). 
The era promoter activity in the· SR-11 maeE cradl craz integrant was slightly down-
regulated (1.1- to 1.4-fold) when grown on two gluconeogenic substrates and one glycolytic substrate, 
versus the SR-11 cradl craz integrant control strain (Table 8). In the SR-11 maeE cradl craz integrant, 
an increase in the concentration of its redwidant sfcA-encoded NAD-dependent malic enzyme should 
be expected; mutational analysis has demonstrated that the malic enzymes can compensate for each 
other in acetate-grown cultures (317). It is possible that the same occurs in glucose-grown, succinate-
grown, and malate-grown cultures. This minor down-regulation in the era promoter activity of the SR-
11 maeB" cradl craz integrant may be due to an increased concentration of the efcA-encoded malic 
enzyme. 
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The era promoter activity was significantly (P = 0.05) up-regulated (2.3- to 2.8-fold) in the 
SR- l l sfeA- cradl craz integrant grown on both gluconeogenic and glycolytic substrates, versus the SR-
11 cradl craz integrant control strain (Table 8). This significant up-regulation becomes more striking 
when focused at the extremely high J3-galactosidase units observed: 7.0 units for growth on succinate 
and 8.2 units for growth on malate (Table 8). The efeA-encoded NAD-dependent malic enzyme 
appears to function as a transcriptional repressor, or play a role in the transcriptional repression, of the 
global regulatory era gene. 
Similar to the SR-11 sfeA- cradl craz integrant, the era promoter activity was significantly 
considerably up-regulated (3.0- to 3.4-fold) in the SR-11 ptd cradl craz integrant on both 
gluconeogenic and glycolytic substrates, versus the control strain (Table 12). Although the J3-
galactosidase activities were slightly lower in the SR-11 cradl craz integrant control strain for this set 
of assays, the ratio of units of J3-galactosidase for each substrate, relative to units of J3-galactosidase for 
the SR-11 cradl craz integrant control strain, compensates for this and reveals a clearer view of the era 
promoter activity (Table 12). It appears that a repressor of the era gene ceased to function in the SR-
11 pta- cradl craz integrant: this implicates acetyl phosphate, indirectly or directly, in the regulation of 
the era gene. 
Virulence of the S. typhimu.rium SR-11 maeK, SR-11 sfcA-, and SR-11 pta- mutants in 
BALB/c mice. Both the SR-11 maeR and SR-11 sft:A- mutants were virulent in BALB/c mice (Table 
9). Since an efeA- mutant strain of S. typhimurium, deficient in the NAD-dependent malic enzyme, was 
reported to be avirulent in mice, a second virulence experiment was performed utilizing more mature 
mice (20, 80). The SR-11 sfeA- mutant strain proved to be virulent in more mature BALB/c mice 
(Table 10). It was later determined that the sfeA- mutant strain reported to be avirulent, was submitted 
to the American Type Culture Collection (A TCC) as a strain of S. typhimurium, but the ATCC 
characterized this strain as S. eholeraesuis (a swine pathogen) (320). The pathogenicity of a S. 
choleraesuis sfcA- mutant strain may deviate from the pathogenicity of a S. typhimurium sfeA- mutant 
strain in the mouse model. 
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Tue SR-11 ptd mutant strain was found to be avirulent in BALB/c mice (Table 13). The 
mice exhibited symptoms of murine typhoid fever, but the intensity of the disease was not as 
prooounced as the mice fed the SR-11 wild-type strain. Two mice recovered by Day14 ofthe 
experiment and the remaining two mice were also recovering. The cfu recovered from the livers and 
spleens of the mice fed the SR-11 ptd mutant strain (6.9 x 106 cfu and 6.7 x 106 cfu respectively), 
sacrificed on Day15, were 1.3 logs less than numbers of bacteria recovered from the mice fed the SR-11 
wild-type control strain (Table 13). Since the SR-11 pta- mutant strain cannot synthesize acetyl 
phosphate from acetyl-CoA and acetyl phosphate is a known global regulator, it appears that an 
essential virulence factor was not induced (24, 79). 
Mouse typhoid infections are directly dependent on the toxicity of lipid A (9). A S. 
typmmurium waaN, lacking a single acyl chain on its lipid A domain of LPS molecules, was 90% 
avirulent in BALB/c mice (9). Extremely high counts of bacteria (109 cfu) were recovered from the 
livers and spleens of the mice (9). Most of the mice carrying the high bacterial loads slowly cleared 
the Salmonella from their organs (9). Perhaps acetyl phosphate, regulating over fifty different two-
component signal transduction systems in E. coli, is involved in the regulation of lipid A biosynthesis 
(24). The SR-11 ptd mutant strain may also have an altered lipid A component, since it cannot 
synthesize acetyl phosphate from acetyl-CoA. 
Another possibility of an essential virulence factor not induced in the SR-11 pta- mutant strain 
is the SPI-2 type III secretion system (22, 56). The two-component signal transduction system, SsrA-
SsrB, is required for SPI-2 gene expression of the SPI-2 type Ill secretion system as well as its 
translocated effectors (22, 56). SsrA-SsrB is positively regulated by the OmpR-EnvZ two-component 
system (22, 56). Acetyl phosphate is a major secondary source of phosphoryl groups for response 
regulators of two-component signal transduction pathways; in E. coli, acetyl phosphate has been 
shown to phosphorylate OmpR in vivo (24, 25, 79, 190). Acetyl phosphate is not synthesized in the 
SR-11 pta- mutant strain. 
The efcA-encoded NAD-dependent malic enzyme and acetyl phosphate may act in 
concert as a repressor of the era gene. The SR-11 sfcA- and SR-11 pta- mutants both exhibited 
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significant (P = 0.05) up-regulation of era promoter activity for growth on both gluconeogenic and 
glycolytic substrates. This significant up-regulation, combined with their virulence da~ suggest that 
the sfeA-encoded NAD-dependent malic enzyme and acetyl phosphate may act in concert as co-
repressors of the era gene. Acetyl phosphate may phosphorylate or bind to the tetrameric NAD-
dependent malic enzyme causing a conformational change in the enzyme (24, 79, 81, 321). The 
pbosphorylated enzyme or phosphorylated enzyme complex may then bind to the operator downstream 
of the era promoter which might repress transcription of the era gene. If so, a concomitant depression 
of~-galactosidase activity would be observed (Figure 20). In the absence of either the sfeA-encoded 
NAD-dependent malic enzyme or acetyl phosphate, negative regulation of the era gene would not 
occur; transcription of the era gene would be up-regulated and more of the Cra protein would 
subsequently be produced (Figure 20). A concomitant elevation of ~-galactosidase activity should also 
be observed. It is assumed that the degree of repression of the era gene is also dependent on the 
concentrations of both the NAD-dependent malic enzyme and acetyl phosphate within the cell. 
To date, the NAD-dependent malic enzyme has only been crystallized from the human 
mitochondrion, which is 57% similar to the efcA-encoded NAD-dependent malic enzyme in S. 
typhimurium (277, 278, 322). X-ray diffraction reveals a helix-tum-helix motif which is a recognition 
motif common to many proteins that bind DNA (322, 323). However, this helix-tum-helix motif may 
not exist in the sfeA-encoded NAD-dependent malic enzyme. The.protein sequence of the NAD-
dependent malic enzyme from S. typhimurium does not contain the DNA-binding helix-tum-helix 
consensus sequence of the Lacl-GalR family of bacterial transcription regulatory factors (321, 324). 
The Lacl-GalR family of bacterial transcription regulatory factors contains over 25 regulatory DNA-
binding proteins including the CRP and Cra proteins (324, 325). The NAD-dependent malic enzyme 
may bind DNA by an alternative mechanism from the Lacl-GalR family of bacterial transcription 
regulatory factors. 
Does the data fully support the hypothesis? One component of the data does not: the units of 
~-galactosidase in the SR-11 sfeA- mutant grown on glucose and fructose (3.8 units and 2.6 units 
respectively) are not at the same levels observed for growth on succinate and malate (7.0 units and 8.2 
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units respectively) (Table 8). If the efcA-encoded NAD-dependent malic enzyme is an integral 
component of a repressor of the era gene, it seems logical to expect similar J3-galactosidase activity for 
growth in both glycolytic and gluconeogenic substrates; the era gene should be derepressed in a SR-11 
sfcA- mutant. The ratio of units of J3-galactosidase, for each substrate, relative to writs of J3-
galactosidase for the SR-11 cradl craz integrant control strain are similarly increased, but the actual 
units are not (Table 8). It appears that the transcription of the era gene, like many other genes and 
operons, is subject to regulation by multiple regulatory proteins or multiple forms of regulation. 
The orientation of the era promoter-/acZ transcriptional fusion versus the wild-type era 
gene in the SR-11 cradl craz strains. A second possibility, although tmlikely, to explain the 
significant differences in the era promoter activities of the SR-11 maeR cradl craz integrant, SR-11 
sfcA- cradl craz integrant, the SR-11 pta- cradl craz integrant, and the SR-11 cradl craz integrant 
control strain, involves the orientation of the era promoter-lacZ transcriptional fusion versus the wild-
type era gene. If the orientation of the era promoter-/acZtranscriptional fusion and the wild-type era 
gene, in the SR-11 maeR cradl craz integrant and the SR-11 cradl craz integrant control strain, is 
inverted versus the other two strains, then there is a slight possibility of an transcriptional regulatory 
effect occurring in a distant location upstream of the era promoter-/acZtranscriptional fusion (Figure 
21). This seems highly improbable since approximately 947 bp ofDNA upstream of the era promoter 
was engineered into these constructs to retain any possible regulatory sequences (Figure 5) (256, 259). 
Reported regulation of the era gene by catabolite repression. It has been suggested, that 
FruR (encoded by the fruR gene; homologous to the Cra protein in S. typhimurium) synthesis in E. coli 
is subject to control by the cyclic AMP receptor protein (CRP) (213). Catabolite repression involves 
the cytoplasmic sensor of carbon and energy concentrations, cAMP, and the CRP protein; cAMP binds 
to CRP at specific DNA sequences in promoters, induces bends in the DNA, and interacts with RNA 
polymerase to promote transcriptional initiation (184, 185). However, the mechanism of cAMP-CRP 
regulation varies; CRP can function not only as an activator, but also as a repressor depending where it 
binds relative to the promoter ( 184, 185). Adenylate cyclase, which catalyzes the formation of cAMP 
from ATP, is more active when cellular concentrations of catabolites are low and less active when 
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catabolite concen~ations are high ( 186). The synthesis of cAMP is regulated by a protein 
phosphorylation mechanism that is catalyzed by the PTS system; exogenous PTS sugars (i.e. glucose, 
fructose, mannitol) inhibit the synthesis of cAMP (91 , 94, 184). 
Catabolite repression of the era gene would explain the lower f3-galactosidase activity 
obserVed in SR-11 sfcA- cradl craz integrant and the SR-11 cradl craz integrant control strain grown in 
glycolytic substrates versus gluconeogenic substrates (Table 6, 8). For transcriptional activation, the 
CRP protein generally binds at two sites upstream of the promoter: -45 to -49 and -70 to -74 bp 
upstream of the transcriptional start site (326). In order to determine ifthe era gene is subjected to 
catabolite repression, the DNA binding consensus sequence of the CRP protein 
[5'-CGCAATIAATGTGAGTI AGCTCACTCATTAGGCA-3'] was compared to the DNA sequence 
of the era promoter of S. typhimurium (71, 323). Absolutely no significant homology was detected 
within 200 bp upstream and downstream of the + 1 transcription start site; the CRP does not appear to 
bind to the era promoter and is not subjected to catabolite repression (183). 
Putative phosphorylated-ArcA DNA-binding sequence in the promoter of the era gene. 
The IO bp DNA binding site consensus sequence for phosphorylated-ArcA (ArcA-P) is 5'-[A!f] 
GTIAATIA[A!f]-3' (193). The -35 DNA sequence ("35 bp upstream of the transcriptional start site") 
of the era promoter is within the DNA sequence 5'-ATGTIAACGATIITAA-3' and the tmderlined 
bases match the first six bases of the ArcA-P DNA binding site consensus sequence (33, 193). A gap 
of five bp follows and then the remaining four bases (italicized) of the ArcA-P DNA binding site 
consensus sequence continues. It is possible that the ArcA-P response regulator can bind and repress 
the transcription of the era gene at this ArcA-P consensus sequence; considerable diversity in the 
consensus sequence, specifically in the last four bases, occurs in many operons regulated by the ArcA-
ArcB two component regulatory system (193). For example, diversity in base substitution of the 
ArcA-P binding site consensus sequence is encountered in gltA (citrate synthase) and the sdhCDAB 
(succinate dehydrogenase) promoters (193). At least eleven other promoters, shown to bind the ArcA-
P response regulator, contain base substitutions (including C and G base substitutions) in the last four 
base sequences of the ArcA-P binding site consensus sequence (193). 
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Summary. Mutations in thejbp, maeB, or the sfrA genes of S. typhimurium SR-11 remained 
virulent in BALB/c mice when administered peroraly. Conversely, a mutation in the pta gene 
attenuated the S. typhimurium SR-11 strain, and avirulence was observed in BALB/c mice. The era 
promoter activity was higher in the S. typhimurium SR-11 cradl craz integrant control strain when 
grown on gluconeogenic substrates versus glycolytic substrates. A mutation in the maeB gene slightly 
down-regulated the era promoter activity when grown on either gluconeogenic or glycolytic substrates. 
In contrast, mutations in either the sfrA or the pta gene significantly (P = 0.05) up-regulated the era 
promoter activity for growth on both gluconeogenic and glycolytic substrates. This significant up-
regulation, combined with their virulence in BALB/c mice, suggest that the sfrA-encoded NAD-
dependent malic enzyme and acetyl phosphate act in concert as a repressor of the era gene. It also 
appears that the era gene, like many other genes and operons, may be subject to regulation by multiple 
regulatory proteins or multiple forms of regulation. 
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Table 1. Bacterial strains and plasmids 
--Strain or plasmid: Relevant genotype and/or phenotype: Source or 
reference: 
i-- Salmonella typhimurium 
strains (plasmid): 
SR-11 gyr 1816/nalidixic acid resistant (197) 
SR-11 Fad- gyr 1816 era: :Tnl Od cam/chloramphenicol resistant (210) 
SR-11 Fad- (pJHA8) gyr1816 cra::TnlOd cam, (era+ tel) (33) 
SR-11~jb[£am1-3 integrant gyr 1816 jbp-jbp + cam bla tetAR This study 
SR-11 ~jb[£am AX-3 gyr1816jbp- cam This study 
segregant 
SR-11 ~jb[£am AX-3 gyr1816jbp- cam (blafbp1 This study 
segregant (pJHA-jbp 1 
SR-11 (pKD46) gyr 1816 ( bla kan ParaB y ~ exo )/kanamycin resistant This study 
arabinose-inducible promoter for 'A Red recombinase 
SR-11 cradl craz integrant gyr1816 era+ bla tetAR/cra promoter-/acZ:fusion (256) 
SR-11 maeR gyr 1816 maeR kan This study 
SR-11 maeR gyr 1816 maeR bla tetAR kan/cra promoter- This study 
cradl craz integrant lacZ:fusion 
SR-11 sfcA- gyr1816 sfcA- k!ffZ This study 
SR-11 sfcA- gyr 1816 sfcA- bla tetAR kan /era promoter- This study 
cradl craz integrant lacZ:fusion 
SR-11 pta- gyr1816ptd kan This study 
SR-11 ptdcradl craz gyr 1816 ptd bla tetAR kan /era promoter- This study 
integrant /acZ:fusion 
MS1868 leu414 hsdL fels2/restriction- modification+ (RM1 K. L. 
Roland 
(304) 
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Table 1. Bacterial strains and plasmids (continued) 
.----
Strain or plasmid: Relevant genotype and/or phenotype: Source or 
reference: 
~. coli strains (plasmids): 
HBlOl p- thi-1 hsdSlO (rB-, mB) supE44 recA13 ara14 leuB6 Promega 
proA2 lacTI galK2 rpsL20(str}xyl-5 mtl-l A.- (Madison, 
/general cloning strain WI) 
XLl-Blue MRF' Li(mcrA)l83 Li(mcrCB-hsdSMR-mrr)l 73 endAl Stratagene 
supE44 thi-l recAl gyrA96 re/Al lac [F' proAB lacP (La Jolla, 
UM15 Tn5 (Kar{)]/general cloning strain CA) 
SI 7-1 "A.pir E.coli K-12 Tpr Smr recA thi hsd.RM" RP4::2- V.de 
Tc::Mu::Km tn7, 'A.pirphage lysogen/Host for Lorenzo 
pLDSS, p554fbpCam, and pMLSScradl-craz (274) 
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Table 1. Bacterial strains and plasmids (continued) 
r----
Strain or plasmid: Relevant phenotype and/or genotype: Source or 
reference: 
i--- Plasmids: 
pBR322 cloning vectorlbla tel (303) 
pJHA7 4.5 kb Pst I fragment containing cra::TnJOd cam in (33) 
pBluescript II SK ( + )/bla 
pJHA8 1.4 kb era+ gene in Pst I site ofpBR322/tet This study 
pBluescript II SK ( +) phagemid cloning vector/bla lacZ (267, 268) 
pJHA-jbp+ 3.1 kb Not I!Xho I fragment containing thejbp+ This study 
gene in pBluescript II SK (+)lbla 
p~jb/£,am 3.5 kb Not I!Xho I fragment containing a deletedjbp gene This study 
ligated to the 1.4 kb chloramphenicol resistance 
cassette in pBluescript II SK (+)/cam bla 
pLD55 suicide vector for allelic exchange/bla tetAR (257) 
p55~jbpCam 3.5 kb Not I!Xho I fragment containing a deletedjbp gene This study 
ligated to the 1. 4 kb chloramphenicol resistance 
cassette in pLD55/cam bla tetAR 
pML55cradl-craz 5.3 kb Pst I fragment containing a era promoter-lacZ (256) 
transcriptional fusion and flanking era upstream and 
downstream genes in the suicide vector pLD55/b/a tetAR 
pKD4 template plasmid used in allelic exchange for amplification (281) 
of the kanamycin resistance cassette by PC,R/bla kan 
pKD46 temperature sensitive plasmid used for allelic exchange with (281) 
an arabinose-inducible promoter for /....Red recombinase!bla 
ParaBY ~ exo 
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Table 2. Primers used in the amplification of DNA by PCR 
.----
Primer: DNA sequence and restriction endonuclease sites: 
i---
-yijF/forward 5'-ATAAGAATGCGGCCGCTACGGTIATIGGTAGGGAGAGC-3' Not I 
yijGlreverse 5'-GCTAGCTCGAGGTTGTGCATGTTATGTICGCCG-3' Xho I 
i-
....-- jbp-DEL 5'-ACTAGGGATCCAAGTACAGATITACCTGAAATGCG-3' Barn HI 
/forward 
jbp-DEL 5'-ACTAGGGATCCAACGTA TICTGGATATCA TICCGG-3' Barn HI 
/reverse 
maeB-DEL 5'-CGTACAGAGGCGATCGGCGTTAATACAIGTACCGGTITAGACACGC 
/forward ATAIGAATATCCTCCITAG-3' 
maeB-DEL 5' -GCGCCCTTGATTICCACGAA TTICCGGTACCCGGT AAAATTCAGG 
/reverse IGTAGGCIGGAGCIGCITCG-3' 
maeB-Flank 5'-ACTAGCTGCAGCCGGTIAGCGCGAGGATITGC-3' Pst I 
/forward 
maeB-Flank 5'-ACTAGCTGCAGCACCGACTATICTTIGTATTACTACC-3' Pstl 
/reverse 
sfcA-DEL 5' -GCACGTICCCTTI ATATCCCTI ACGCTGGCCCTGTA TIGCTGGAA 
/forward IGTAGGCIGGAGCIGCITCG-3' 
sfcA-DEL 5' -CGCCTGTIGCAGCGCTICCGCAGAGGTTITCACCGCTACGCCTTG 
/reverse CATAIGAATATCCTCCITAG-3' 
sfcA-Flank 5'-ACTAGCTCGAGTCAGTGATGAATATTAAACCAACAGG-3' Xho I 
/forward 
sfcA-Flank 5' -ACTAGCTCGAGTGCACAATTITAGCCGCATCTICCG-3' Xho I 
/reverse 
Underlined DNA sequences represent restriction endonuclease sites. Italicized sequences are 
complementary to the flanking sequences in the kanamycin cassette of pKD4 (Table 1 ). DEL 
denotes a primer used for deleting, and confirming the the deletion, of a gene. Flank denotes a 
primer flanking the gene of interest used for confirming the wild-type and deleted genes. 
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Table 2. Primers used in the amplification of DNA by PCR (continued) 
r---
J>rimer: DNA sequence and restriction endonuclease sites: 
i---
~pta-DEL 5' -CTACCGGAACCAGCGTCGGCCTGACCAGCGTCAGCCTCGGCGTCA 
/forward TGTAGGCTGGAGCTGC1TCG-3' 
pta-DEL 5' -CGATGGAGATCAGGTCGGCAGAACGCTGTACCGCTITGTAGGTGG 
/reverse CATATGAATATCCTCCITAG-3' 
i--
r- pta-Flank 5'-ACTAGATIATIGGATGCAGTCGTGTTCACCG-3' Ase I 
/forward 
pta-Flank 5'-ACTAGATIATITAGTTATTCATIGATGCAGCGC-3' Ase I 
/reverse 
r-
era-COMP 5' -ATCGACTGCAGTGCGAAATCCGTGGTAACCCGG-3' Pst I 
/forward 
era-COMP 5' -TAGCTCTGCAGCCTGTITAACGTGTGCGGTGCC-3' Pst I 
/reverse 
/ae7Jreverse 5' -TAGATCGAATGCCTTATITITGACACCAGACCAACTGG-3' Bsm I 
Underlined DNA sequences represent restriction endonuclease sites. Italicized sequences are 
complementary to the flanking sequences in the kanamycin cassette of pKD4 (Table 1 ). DEL 
denotes a primer used for deleting, and confirming the deletion, of a gene. Flank denotes a primer 
flanking the gene of interest used for confirming the wild-type and deleted genes. COMP denotes 
a primer utilized to clone, and confirm the cloning, of a gene. A cloned gene, amplified with a 
COMP primer, was intended to complement a deleted gene. The /acZ/reverse primer was utilized 
to confirm the cra-lacZ transcriptional fusion in S. typhimurium SR-11 cradl craz integrant strains. 
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Table 3. Growth of Salmonella typhimurium SR-11 wild-type, SR-11 Fad·, and SR-11 
ajbpC,am AX-3 jbp- segregant on M9 minimal agar plates supplemented with various 
carbon sources 
Carbon source: SR-11 wild-type: SR-11 Fad-: SR-11 AjbpCam AX-3 
fop- segregant: 
....--
....... glucose: (+) (+) (+) 
i--
gluconate: (+) (+) (+) 
t-" 
...--
alanine: (+) (-) (-) 
citrate: (+) (-) (-) 
fumarate: (+) (-) (-) 
glycerol: (+) (+) (-) 
oleate: (+) (-) (-) 
pyruvate: (+) (-) (-) 
succinate: (+) (-) (-) 
The M9 minimal agar plates, supplemented with various carbon sources, were incubated @ 3 7°C for 
45 hours. A ( +) denotes growth to at least the third quadrant on the plate. A (-) denotes no growth. 
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Table 4. Virulence of Salmonella typhimu.rium SR-ll wild-type, SR-11 Fad-, and SR-11 
AjbpC,am AX-3jbp- segregant in 4.0 week-old female BALB/c mice 
.----
strain:• Virulence: Day of expiration post 
(survival) peroral inoculation: 
(mean± std. deviation) 
i--
- SR-11 
wild-type 0/4 7.5 ± 1.0 
-
-sR-11 
Fad- 4/4* NIA~ 
-
SR-11 
jbp- 0/4 7.5 ± 1.0 
sham 
infected 4/4 NIA~ 
~ 
• peroral moculation of approxtmately 2.4 x 10 cfu. 
•mice sacrificed on Day13 of virulence experiment. 
~NI A denotes not applicable. 
Log[ cfU/liver]: 
(mean ± std. deviation) 
8.33 ± 0.58 
3.41±0.34* 
8.18±0.15 
NIA~ 
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Log[ cfU/spleen]: 
(mean± std. deviation) 
8.00 ± 0.34 
3.84 ± 0.31 * 
8.11 ±0.20 
NIA~ 
Table 5. Generation time and (3-galactosidase activity of Salmonella typhimurium 
SR-11 cradl craz integrant grown in M9 minimal broth supplemented with 
various carbon sources~ 
r----
Carbon source: Mean generation time: Units of J3-galactosidase*: 
(minutes ± std. deviation) (mean± std. deviation ) 
i--
.--- succinate: 109±15, n =3 3.3 ± 0.7, n =9+ 
......-
t"-" malate: 103±10, n=3 2.7 ± 0.6, n =9<-
.---
pyruvate: 102 ±20 ,n=2 2.4 ± 0.2, n =3<· 
t"-" 
citrate: 93 ± 5, n =3 2.2 ± 0.1, n =6'°' 
oleate: 148 ± 25, n =2 1.9 ± 0.1 , n =3 + 
acetate: 213 ± 18, n=2 1.8 ± 0.1, n =3'°' 
phospho( enol)pyruvate: 78, n =1 1. 7 ± 0.1 , n =3'°' 
glucose: 90±4,n=7 1.3 ± 0.2 , n =21 ·> 
gluconate: 67 ±4, n =3 1.0 ± 0.2 , n =9'°' 
fructose: 73 ±5 ,n=4 0.9 ± 0.1, n =12<· 
SR-11 wild-type: 
glucose: 73, n=l 0.0 ± 0.0, n =3+ 
~grown m the presence of 150 µg/ml of ampicillin to maintain the integrant (257). 
• assayed @ OD500 of~ 1.0 
• ~-galactosidase assays were performed~ triplicate for each culture. 
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,---
i--
~ 
t--
t--" 
Table 6. Ratio of J3-galactosidase activity of S. typhimu.rium SR-11 cradl craz integrant 
grown in M9 minimal broth supplemented with various carbon sources relative to 
p-galactosidase activity of Salmonella typhimu.rium SR-11 cradl craz integrant 
grown in M9 minimal broth supplemented with fructose-¢-
Carbon source: Units of p-galactosidase*: Ratio of J3-galactosidase units 
(mean± std. deviation) relative to J3-galactosidase units 
for fructose: 
succinate: 3.3 ± 0. 7, n =9-=- 3.6 
malate: 2.7 ± 0.6, n =9·:· 3.0 
pyruvate: 2.4 ± 0.2 , n =3-=- 2.6 
citrate: 2.2 ± 0.1, n =6-=- 2.4 
oleate: 1.9±0.l ,n=3+ 2.1 
acetate: 1.8 ± 0.1, n =3+ 2.0 
phospho( enol)pyruvate: 1.7 ± 0.1, n =3• 1.8 
glucose: 1.3 ± 0.2 , n =21 <- 1.4 
gluconate: 1.0 ± 0.2 , n =9-=- 1.0 
fructose: 0.9 ± 0.1, n =12<· 1.0 
~ grown m the presence of 150 µglml of ampicillin to maintain the integrant (257). 
• assayed @ OD500 of~ 1.0 
• ~-galactosidase assays were performed in triplicate for each culture. 
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Table 7. Generation times of Salmonella typhimu.rium SR-11 maeH, SR-11 sfcA-, and SR-11 
wild-type grown in M9 minimal broth supplemented with various carbon sources~ 
.---
Strain: Carbon source: Generation time: 
(minutes) 
i--
r- SR-11 wild-type: glucose 80 
r-- SR-11 maeE: glucose 82 
r--- SR-11 sfcA-: glucose 89 
r- SR-11 wild-type: fructose 72 
r-- SR-11 maeE: fructose 82 
SR-11 sfcA-: fructose 77 
SR-11 wild-type: succinate 78 
SR-11 maeE: succinate 106 
SR-11 sfcA-: succinate 94 
SR-11 wild-type: malate 82 
SR-11 maeE: malate 186 
SR-11 sfcA-: malate 145 
~grown in the presence of 50 µglml of na11dixic acid 
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Table 8. (3-galactosidase activity of S. typhimu.rium SR-11 maeR cradl craz integrant, SR-11 
sfcA- cradl craz integrant, and SR-11 cradl craz integrant grown in M9 minimal broth 
supplemented with various carbon sources~ 
..---
Strain: Carbon Units of J3- Ratio of units of J3-galactosidase, 
source: galactosidase*: for each substate, relative to units 
(mean± std. deviation) of J3-galactosidase for the SR-11 
cradl craz integrant control strain: 
i--
i- SR-11 cradl craz 
integrant: succinate 3.1±0.4, n =15-> 1.0 
r- SR-11 maeR cradl 
craz integrant: succinate 2.0 ± 0.3 , n =9• 0.7 
SR-11 sfcA- cradl 
craz integrant: succinate 7.0 ± 0.7, n =9·:· 2.3 
SR-11 cradl craz 
integrant: malate 3.0 ± 0.3 , n =15+ 1.0 
SR-11 maeR cradl 
craz integrant: malate 2. 7 ± 0.1 , n =6• 0.9 
SR-11 sfcA- cradl 
craz integrant: malate 8.2 ± 0.4 , n =6+ 2.8 
SR-11 cradl craz 
integrant: glucose 1.4 ± 0.2, n =27-> 1.0 
SR-11 maeR cradl 
craz integrant: glucose 1.3 ± 0.1, n =9-=- 0.9 
SR-11 sfcA- cradl 
craz integrant: glucose 3.8 ± 0.5 , n =9·> 2.7 
SR-11 cradl craz 
integrant: fructose 1.1 ± 0.2, n =18-:- 1.0 
SR-11 maeR cradl 
craz integrant: fructose 1.1+0.2, n =9• 1.0 
SR-11 sfcA· cradl 
craz integrant: fructose 2.6 + 0.5 , n =12+ 2.5 
~ grown m the presence of 150 µglml of ampicillin to maintain the integrants (257). 
• assayed @ OD500 of~ 1.0 ~ ~-galactosidase assays were performed in triplicate for each culture. 
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T ble 9. Virulence of Salmonella typhimurium SR-11 wild-type, SR-11 maen-, and SR-11 sfcK 
a in 4.4 week-old female BALB/c mice 
.-----
strain:• Virulence: Day of expiration post 
(survival) peroral inoculation: 
(mean± std. deviation) 
t--
r--SR-11 
wild-type 0/4 7.0 ± 1.2 
......-
i--SR-11 
maeR 0/4 6.5 ± 1.3 
SR-11 
sfcA- 0/4 8.0 ± 1.6 
sham 
infected 4/4 NJA-9-
\g-
• peroral moculation of approxunately 1.3 x 10 cfu. 
~NI A denotes not applicable. 
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Log[ du/liver]: Log[cfu/spleen]: 
(mean± std. deviation) (mean± std. deviation) 
8.15 ±0.10 7.98±0.06 
7.68 ± 0.45 7.59 ± 0.25 
7.19 ± 0.30 6.90 ± 0.43 
NJA-9- NJA-9-
Table 10. Virulence of Salmonella typhimurium SR-11 wild-type and SR-11 sfcA- in 
7.1 week-old female BALB/c mice 
.-----
strain:• Virulence: Day of expiration post Log[ du/liver]: Log[ cfU/spleen]: (survival) peroral inoculation: (mean± std. deviation) (mean± std. deviation) 
(mean± std. deviation) 
i--
~ SR-11 
wild-type 0/2 8.0 ± 1.4 7.65 ± 1.11 7.49±1.38 
i--
~SR-11 
sfcA- 013 7.0 ± 1.7 7.82 ± 0.34 7.69 ± 0.15 
i--
~s 
• peroral moculation of approxnnately 2.1 x 10 cfu. 
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Table 11. Generation times of Salmonella typhimu.rium SR-11 pta- cradl craz integrant and 
SR-11 cradl craz integrant grown in M9 minimal broth supple_mented with various 
carbon sources-9-
.----
Strain: Carbon source: Generation time: 
(minutes) 
i---
-
SR-11 cradl craz integrant: glucose 75 
..--- SR-11 ptd cradl craz integrant: glucose 94 
...... 
-
SR-11 cradl craz integrant: fructose 70 
-- SR-11 pta- cradl craz integrant: fructose 101 
SR-11 cradl craz inte~ant: succinate 200 
SR-11 pJa- cradl craz int~ant: succinate 213 
SR-11 cradl craz integrant: malate 199 
SR-11.J!!d cradl craz intel[_ant: malate 192 
~grown in the presence of 150 µglml of ampicillin to maintain the integrants (257). 
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T ble 12. (3-galactosidase activity of S. typhimllrium SR-11 pta- cradl craz integrant and SR-11 c~adl craz integrant grown in M9 minimal broth supplemented with various carbon sources-¢-
,.----
Strain: Carbon Units of (3- Ratio of units of (3-galactosidase, 
source: galactosidase*: for each substrate, relative to units 
(mean± std. deviation) of (3-galactosidase for the SR-11 
cradl craz integrant control strain: 
i--
r- SR-11 cradl craz 
integrant: succinate 2.0 ± 0.1, n =3'°' 1.0 
SR-11 pta- cradl 
craz integrant: succinate 6.3 ± 0.2, n =3'°' 3.1 
SR-11 cradl craz 
integrant: malate 1.6 ± 0.3 , n =3'°' 1.0 
SR-11 pta- cradl 
craz integrant: malate 4.7 ± 0.7, n =3'°' 3.0 
SR-11 cradl craz 
integrant: glucose 0.7 ± 0.1, n =3• 1.0 
SR-11 pta- cradl 
craz integrant: glucose 2.5 ± 0.1, n =3• 3.4 
SR-11 cradl craz 
integrant: fructose l.2±0.l ,n=3'°' 1.0 
SR-11 ptd cradl 
craz integrant: fructose 3.7±0.l ,n=3'°' 3.0 
-¢- grown in the presence of 150 µ!¥ml of ampicillin to maintain the integrants (257). 
• assayed @ OD500 of::::: 1.0 . 
• (3-galactosidase assays were performed in triplicate for each culture. 
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Table 13. Virulence of Salmonella typhimurium SR-11 wild-type and SR-11 pta- in 4.4 week-old 
female BALB/c mice 
.-----
strain:• Virulence: Day of expiration post 
(survival) peroral inoculation: 
(mean± std. deviation) 
r-
.-SR-11 
wild-type 014 7.0 ± 1.2 
-
SR-11 
pta- 414* NIA~ 
sham 
infected 414 NIA~ 
Jr 
+ peroral moculatton of approXlIDately 1.6 x 10 cfu. 
•mice sacrificed on Day15 of virulence experiment. 
~NI A denotes not applicable. 
Log[ du/liver]: 
(mean± std. deviation) 
8.15 ±0.10 
6.85 ± 1.36* 
NIA~ 
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Log[cfu/spleen]: 
(mean± std. deviation) 
7.98±0.06 
6.69±1.14* 
NIA~ 
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Figure 1. The major metabolic pathways of Salmonella typhimurium. The Emlxlen-Meyerhof 
Pathway, the pentose phosphate cycle, the tricarboxylic acid cycle (TCA), and the Entner-Doudoroff 
Pathway are shown above and represent the fueling pathways in central metabolism (72, 73). The 
glyoxylate shllllt, when induced, bypasses several reactions in the TCA cycle (74). Two steps in the 
reversible Emlxlen-Meyerhofpathway are replaced in the gluconeogenic pathway by the pps-encoded 
enzyme phosphoenolpyruvate synthetase and thejbp-encoded enzyme fructoste-1 ,6-bisphosphatase 
(73, 82, 120). The pathways for acetate metabolism, fructose metabolism, and fatty acid oxidation 
( ~leate) are also shown above ( 172, 173, 177-179). P represents phosphate in the diagram. Diagram 
highly modified from references (73, 212). 
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Figure 2. The branched, biosynthetic form of the TCA cycle for aerobic growth of S. typhimurium 
utilizing a non-limiting glucose source. The full TCA cycle is not required under these conditions 
because the bulk of energy is derived from glycolysis (74, 78). In this rich environment, cells produce 
excess acetyl-CoA which drains through acetyl phosphate, to further produce A 1P with the associated 
secretion of acetate (78, 79). As cell density increases, the build-up of acetate also serves to increase 
the size of the acetyl phosphate pool (78). P represents phosphate in the diagram. Diagram highly 
modified from references (69, 73, 212). 
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Figure 3. Overview of the transcriptional regulatory effects of the Cra protein on key enzymes in the 
Emlxlen-Meyerhof pathway, the TCA cycle, the glyoxylate shtmt, the gluconeogenic pathway, and the 
Entner-Doudoroffpathway in Salmonella typhimurium; (+)denotes genes positively regulated by Cra~ 
( ~) denotes genes negatively regulated by Cra. P represents phosphate in the diagram. Diagram 
highly modified from reference (69, 73, 212). 
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Figure 4. Model for transcriptional regulation of target genes by the Cra pr~tein. In the absence of 
effector molecules (fructose- I-phosphate and/or fructose-1,6-bisphosphate ), Cra binds to the operator 
site ( o) in the regulatory region of the target gene or operon. Positively regulated genes ( +) are 
activated and negatively regulated genes (- ) are repressed. The binding of effector molecules to the 
Cra protein causes it to dissociate from the DNA, exerting deactivation or derepression of gene 
expression. Diagram highly modified from references (212, 21 7). 
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Figure 5. A control strain, S. typhimurium SR-11 cradl craz integrant, containing a era promoter-laeZ 
transcriptional fusion, was obtained from Mary P. Leatham (256). The strain was constructed by 
conjugative-dependent allele replacement utilizing the suicide vector pML55cradl-craz (256, 257) The 
control strain carries a partial upstream ilvl gene, an upstream RvH gene, the upstream intergenic 
sequence, and the era promoter ligated to the promoterless laeZ gene from pCB267 (256, 258). 
Approximately 947 bp of DNA upstream of the era promoter were engineered into this construct to 
retain any possible regulatory sequences (256, 259). The 3' end of the lacZ reporter gene is ligated to 
approximately 200 bp of the remaining truncated era gene, followed by approximately 534 bp of 
downstream DNA (a partialyabB gene) (256). The SR-11 maeR cradl craz integrant, SR-11 sfeA-
cradl craz integrant, the SR-11 ptd cradl craz integrant were also constructed by this technique 
employing the suicide vector pML55cradl-craz. 
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yif'F 
\ 
Pstl \ 
(5369) 
'\ 
Nol 1(0) 
multiple cloning site 
f T3 promoter 
1 lacZ 
pJIL4- fbp+ 
- 5979 hp 
\ 
col E 1 origin 
/ 
ampicillin 
resistance 
~-lli:fJ•~ ,~ fl ( +) origin 
lacZ 
TI promoter 
multiple cloning site 
,,,\no I (2890) 
Figure 6. The plasmid pJHA:fbp+ was mapped with the restriction endonucleases Not I, Pst I, and 
Xho I. The plasmid contains the entire jbp gene with partial upstream and downstream yifG and yifF 
genes. The amplicon was ligated into the Barn HI/Not I sites of the phagemid cloning vector 
pBluescript II SK ( +) (Table 1 ). The munbers in parentheses, which denote base pairs, are 
approximate. 
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(bp 
yij}i 
PstI\ 
(5369) 
"' 
----t-(3913-4907) 
Nt1t I (0) 
multiple cloning site 
f T3 promoter 
/ lacZ 
col El origin 
I 
' . 
ampicillin 
resistance 
fl ( +) origin 
~ lacZ 
\ 17 promoter 
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Xho I (2890) . 
Figure 7. The plasmid pilIA-jbp+ was utilized as template DNA in a PCRreaction, with the primers 
shown above, to amplify armmd the plasmid (Table 2). The amplicon effectively deleted 878 bp from 
the fbp gene. The PCR prcxluct was then digested with Barn Ill and ligated to itself The munbers in 
parentheses, which denote base pairs, are approximate. 
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Afbp 
(3829-3945) 
BamHI 
(3826) 
yifF 
PsH 
(4433) 
/ 
yif G 
Not I (0) 
multiple cloning site 
/ T3 promoter 
lacZ 
col El origin 
pA(bp 
.-..5017 bp 
,' 
ampicillin 
resistance 
Figure 8. The plasmid p~jbp was mapped with the restriction endonucleases Not I, Pst I, and Xho I. 
The plasmid contains a deleted jbp gene with partial upstream and downstream yifG and yifF genes in 
the cloning vector pBluescript II SK ( +) (Table I). A Bam Ill site was engineered adjacent to the 
deleted fbp gene for insertion of a chloramphenicol resistance cassette. The numbers in parentheses, 
which denote base pairs, are approximate. 
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A(bp 
(5232-5348) 
' BamHl 
(5229) 
chlorarnphenic ol 
resistance cassette.,..,.... 
yifF 
Not l (O) 
multiple cloning site 
/ T3 promoter 
lacZ . . 
col El ongm 
.,,,,,. ...... ~ ...... .::......._, 
ampicillin 
resistance 
pA(bpCam 
-6420 hp 
Bam Hl 
(3826) 
yifG ~ f 1 (+) origin lacZ n promoter multiple cloning site 
.rYho I (2890) 
Figure 9. The plasmid p~jbpCam was mapped with the restriction endonucleases Bam HI, Not I, 
Pst I, and Xho I. The plasmid contains a chloramphenicol resistance cassette adjacent to the deleted 
fbp gene and is flanked by partial upstream and downstream yijG and yifF genes. This insert is 
contained within the Bam IIl!Not I sites of the cloning vector pBluescript II SK(+) (Table 1). The 
numbers in parentheses, which denote base pairs, are approximate. 
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yifJi 
Not l (O) A(bp \ 
(9805-9921) I 
B~\HI multiple cloning site 
(9802) 
chloramphenic ol 
resistance cassette 
yifG 
BamH I 
(8399) 
k7wl 
(7463)......--
multiple cloning site 
p55AfbpCam 
-10993 hp 
bla 
tetR 
tetA 
Figure 10. The plasmid p554fbpCam was mapped with the restriction endonucleases Bam Ill, Not I, 
Pst I, and.Xho I. The plasmid contains a chloramphenicol resistance cassette adjacent to the deleted 
fbp gene and is flanked by partial upstream and downstream yijG and yifF genes. This insert was 
ligated into the.Xho I/Not I sites of the suicide vector pLD55 (Table 1). The nwnbers in parentheses, 
which denote base pairs, are approximate. 
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SR-11 wt genomic DNA 
7~1..- Integrant (partial diploid) 
[ CamR Ajbp TetR Anq>R 
~~--------- L----------.... .._ __ _, 
Figure 11. The first recombinational event of allelic exchange yielded S. typhimurium SR-11 
4/bpCam 1-3 integrant (257). The integrant is a partial diploid, containing both the wild-typefbp and 
deleted jbp genes. 
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Integrant (partial diploid) 
Cam:R A.Jbp TetR 
l{ 
[ ,. ..... Segregant I< /} ;,, CamR A.J1>p 
. c::::Jtl 
Figure 12. The second recombinational event of allelic exchange yielded S. typhimurium SR-11 
4/bpCam AX-3 segregant (239, 257). The segregant contains the deletedjbp gene adjacent to 
chloramphenicol resistance cassette. 
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) 
8 
I 
A Red recombit1ase 
SR-11 wt gDNA 
maeB maeB 
Kan.R 
Figure 13. The linear DNA amplicon containing the kanamycin resistance cassette and homologous 
flanking sequences to the maeB gene was electroporated into competent SR-11 wild-type cells 
containing the plasmid pKD46 (Table 1) (281 ). The gene encoding A. Red recombinase, which greatly 
enhances the rate of homologous recombination, is located the plasmid pKD46 and is controlled by an 
arabinose-inducible promoter. The wild-type gene is replaced by a deleted version and an antibiotic 
resistance marker in one step (281 ). This method was also used to make permanent deletions in the 
sfcA and pta genes. 
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Figure 14. PCR amplification ofthejbp gene in S. typhimurium SR-11 wild-type, SR-11 f!..jbpCam 1-3 
integrant, and SR-11 4fbpCam AX-3 segregant. Lane 1: 1 kb DNA ladder. Lane 2: The SR-11 wild-
type yields a 3.1 kb band which represents the wild-typejbp gene (994 bp) plus approximately 1 kb 
upstream (a partialyifG gene) and approximately 1 kb downstream (a partialyifF gene). Lane 3: The 
SR-11 f!..jbj£,am 1-3 integrant exhibits two bands: one corresponding to the wild-type band and a 3.5 
kb band representing the deleted.fbp gene plus the chloramphenicol resistance cassette. Lane 4: The 
SR-11 4/b/£,am AX-3 segregant yields one 3.5 kb band denoting the deletedfbp gene plus the 
chloramphenicol resistance cassette. The PCR reactions utilized the yi.jF/forward and yi.jG/reverse 
Primers (Table 2), 2.4 mM MgCii, 2.5 % DMSO, and genomic template DNA from the above strains. 
The PCRreactions were subjected to an initial denaturation of94°C for 5 minutes followed by 32 
cycles of: 94°C for 45 seconds, 56°C for 45 seconds, and 72°C for 3 minutes. A final extension of 
72°C for 7 minutes completed the PCR 
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Figure 15. The ratio of (3-galactosidase units for each substrate assayed relative to the (3-galactosidase 
units for fructose. (3-galactosidase assays, for era promoter activity, were performed in SR-11 cradl 
craz integrant grown in M9 minimal broth supplemented separately with D-fructose, D-glucose, D-
gluconic acid potassium salt, potassium acetate, sodium citrate, L(-)malic acid, phospho( enol)pyruvate 
monosodium salt, pyruvic acid sodium salt, oleic acid sodium salt, and succinic acid dissodilllll salt 
(232, 233). A(+) denotes genes positively regulated by the Cra protein; a (- ) denotes genes negatively 
regulated by the Cra protein. P represents phosphate in the diagram. Diagram highly modified from 
references (69, 73, 212). 
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maeB maBB 
Flank/forward Flank/re\rerse 
prime1· KanR p1im.e1· 
~--"---1---· _taL_'.A _ _ m_a_~_B.,.I ~m-~_B __ tn_~_vi ___ 3_~---... ».,._'I" 
.1f . -/7~,---~---
maeB-DEL/fO:nvard maeB-DEL/reverse 
prim.er primer 
Figure 16. PCR primer diagram for confirmation of the deleted maeB gene in the genome of 
S. typhimurium SR-11 maeE. The primer pairs maeB-Flanklforward & reverse, maeB-DEL!forward & 
reverse, maeB-Flanklforward & maeB-DEL!reverse, and maeB-DEL!forward & maeB-Flanklreverse 
were utilized in separate PCR reactions to confirm, by amplicon size, the deletion in the maeB gene. 
The same scheme was employed to confirm deletions in the sfcA and pta genes of S. typhimurium 
SR-11 sfcA- and S. typhimurium SR-11 ptd respectively. 
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Figure 17. PCR amplification of the maeB gene in S. typhimurium SR-11 maeE and SR-11 wild-type. 
Lane 1: 1 kb DNA ladder. Lane 2: The 3.6 kb band (maeB-Ftanklforward & reverse primers) 
represents the deleted maeB gene, kanamycin cassette, plus partial ta/A upstream and tnpA _3 
downstream genes. Lane 3: A 2.5 kb band (maeB-Flanklforward & maeB-DEL/reverse primers) 
reveals the kanamycin cassette, deleted maeB gene, and a partial upstream gene. Lane 4: A 2.6 kb 
band (maeB-Flank/reverse & maeB-DEL!forward primers) corresponds to the kanamycin cassette, 
deleted maeB gene, and a partial downstream gene. Lane 5: The 1.5 kb kanamycin resistance cassette 
(maeB-DEL!forward & reverse primers) inserted in the deleted maeB gene. Lane 6: A 4.2 kb band 
(maeB-Flank:lforward & reverse primers) corresponding to the partial ta/A upstream gene, the wild-
type maeB gene (2280 bp) plus a partial tnpA_3 downstream gene. Lane 7: A(-) DNA control. Lanes 
2-5 utilized SR-11 maeE genomic template DNA and Lane 6 utilized SR-11 wild-type genomic 
template DNA. The PCR reactions contained 1.8 mM MgCii and were subjected to an initial 
denaturation of 94°C for 5 minutes followed by 32 cycles of: 94°C for I minute, 57°C for 1.5 minutes, 
and 72°C for 3 minutes. A final extension of 72°C for 7 minutes completed the PCR 
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Figure 18. PCR amplification of the sfcA gene in S. typhimurium SR-11 sfcA- and SR-11 wild-type. 
Lanel: 1 kb DNA ladder. Lane 2: The 3.6 kb band (sfi:A-Flank /forward & reverse primers) represents 
the deleted sfi:A gene, kanamycin cassette, plus entire upstream rps V gene, partial upstream yddX gene, 
and partial downstream adhP gene. Lane 3: A 2.7 kb band (sfcA-Flanklforward & sfcA -DEL/reverse 
primers) reveals the kanamycin cassette, deleted sfcA gene, and upstream genes. Lane 4: A 2.6 kb 
band (s/cA-Flank/reverse & sfcA-DEL!forward primers) corresponds to the kanamycin cassette, deleted 
sfcA gene, and a partial adhP downstream gene. Lane 5: The 1.5 kb kanamycin resistance cassette 
(sfcA-DEL!furward & reverse primers) inserted in the deleted sfcA gene. Lane 6: A 3. 7 kb band (sfcA-
Flank!forward & reverse primers) corresponding to the wild-type sfcA gene (1697 bp) plus the entire 
upstream rps V gene, partial upstream yddX gene, and partial downstream adhP gene. Lane 7: A (-) 
DNA control. Lanes 2-5 utilized SR-11 sfi:A- genomic template DNA and Lane 6 utilized SR-11 wild-
type genomic template DNA. The PCR reactions contained 1.8 mM MgCli and subjected to an initial 
denaturation of94°C for 5 minutes followed by 32 cycles of: 94°C for 1 minute, 57°C for 1.5 minutes, 
and 72°C for 3 minutes. A final extension of 72°C for 7 minutes completed the PCR 
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Figure 19. PCR amplification of the pta gene in S. typhimurium SR-11 ptd and SR-11 wild-type. 
Lane 1: 1 kb DNA ladder. Lane 2: A (-) DNA control. Lane 3: A 2.0 kb band (pta-Flanklforward & 
pta-DEL/reverse primers) corresponds to the kanamycin cassette, deleted pta gene, and the partial 
upstream ackA gene. Lane 4: A 1.9 kb band (pta-Flankl reverse & pta-DEL!forward primers) reveals 
the kanamycin cassette, deleted pta gene, and downstream sequences. Lane 5: The 2.3 kb band (pta-
Flank /forward & reverse primers) represents the partial upstream ackA gene, the deleted pta gene, the 
kanamycin cassette, plus downstream sequences. Lane 6: The 1.5 kb kanamycin resistance cassette 
(pta-DEL!forward & reverse primers) inserted in the deletedpta gene. Lane 7: A 2.6 kb band (pta-
Flank:/forward & reverse primers) corresponding to the partial upstream ackA gene, the wild-type pta 
gene (2155 bp), plus downstream sequences. Lanes 3-6 utilized SR-11 pta- genomic template DNA 
and Lane 7 utilized SR-11 wild-type genomic template DNA. The PCR reactions contained 1.5 mM 
MgCl2 and were subjected to an initial denaturation of94°C for 5 minutes followed by 32 cycles of: 
94°C for 1 minute, 54°C for 1.5 minutes, and 72°C for 2.5 minutes. A final extension of 72°C for 7 
minutes completed the PCR 
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Figure 20. The sfeA-enccxled, NAO-dependent malic enzyme and acetyl phosphate may act in concert 
as a repressor of the era gene. Top figure: Acetyl phosphate transfers a phosphoryl group to the 
tetrameric, sfeA-enccxled, NAO-dependent malic enzyme then binds to the operator (0) downstream of 
the era promoter; this represses the transcription of the era gene by RNA polymerase. Middle figure: 
Acetyl phosphate binds to the sfeA-enccxled NAO-dependent malic enzyme causing a conformational 
change in the enzyme; the enzyme complex then binds to the operator downstream of the era promoter 
and represses the transcription of the era gene by RNA polymerase. Bottom figure: In the absence of 
either the sfeA-enccxled, NAO-dependent malic enzyme or acetyl phosphate, negative regulation of the 
~ra gene does not occur; RNA polymerase transcribes the era gene and it is subsequently translated 
mto the tetrameric Cra protein. 
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Figure 21. A second possibility, although unlikely, to explain the significant differences in the era 
promoter activities of the SR-11 maeE cradl craz integrant, SR-11 sfeA- cradl craz integrant, the SR-11 
pta- cradl craz integrant, and the SR-11 cradl craz integrant control strain, involves the orientation of 
the era promoter-/aeZtranscriptional fusion versus the wild-type era gene. If the orientation of the era 
promoter-/acZ transcriptional fusion and the wild-type era gene, in the SR-11 cradl craz integrant 
control strain and the SR-11 maeE cradl craz integrant strain, is inverted versus the other two strains, 
then there is a slight possibility of an transcriptional regulatory effect occurring in a distant location 
upstream of the era promoter-/aeZtranscriptional fusion. This seems highly improbable since 
approximately 947 bp of DNA upstream of the era promoter was engineered into these constructs to 
retain any possible regulatory sequences (256, 259). 
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